US20120225006A1 - Nano-sized particles, processes of making, compositions and uses thereof - Google Patents
Nano-sized particles, processes of making, compositions and uses thereof Download PDFInfo
- Publication number
- US20120225006A1 US20120225006A1 US13/444,178 US201213444178A US2012225006A1 US 20120225006 A1 US20120225006 A1 US 20120225006A1 US 201213444178 A US201213444178 A US 201213444178A US 2012225006 A1 US2012225006 A1 US 2012225006A1
- Authority
- US
- United States
- Prior art keywords
- nanoparticles
- zinc oxide
- temperature
- nanocrystals
- oxide nanoparticles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000002105 nanoparticle Substances 0.000 title claims abstract description 187
- 238000000034 method Methods 0.000 title claims abstract description 149
- 239000000203 mixture Substances 0.000 title claims description 54
- -1 processes of making Substances 0.000 title claims description 28
- 239000002245 particle Substances 0.000 title abstract description 42
- 230000008569 process Effects 0.000 title description 6
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 114
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 75
- 239000011787 zinc oxide Substances 0.000 claims description 55
- 230000015572 biosynthetic process Effects 0.000 claims description 34
- 239000002904 solvent Substances 0.000 claims description 33
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 32
- 239000002243 precursor Substances 0.000 claims description 32
- 239000003960 organic solvent Substances 0.000 claims description 31
- 239000005642 Oleic acid Substances 0.000 claims description 30
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims description 29
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims description 29
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims description 29
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims description 29
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims description 29
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 29
- 239000003446 ligand Substances 0.000 claims description 28
- 230000003647 oxidation Effects 0.000 claims description 26
- 238000007254 oxidation reaction Methods 0.000 claims description 26
- 239000002073 nanorod Substances 0.000 claims description 18
- 230000000087 stabilizing effect Effects 0.000 claims description 18
- 239000004215 Carbon black (E152) Substances 0.000 claims description 17
- 229930195733 hydrocarbon Natural products 0.000 claims description 17
- 150000002430 hydrocarbons Chemical class 0.000 claims description 17
- 238000001556 precipitation Methods 0.000 claims description 17
- 125000005270 trialkylamine group Chemical group 0.000 claims description 16
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 claims description 13
- 239000004246 zinc acetate Substances 0.000 claims description 13
- XTAZYLNFDRKIHJ-UHFFFAOYSA-N n,n-dioctyloctan-1-amine Chemical group CCCCCCCCN(CCCCCCCC)CCCCCCCC XTAZYLNFDRKIHJ-UHFFFAOYSA-N 0.000 claims description 12
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 9
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 9
- 238000000354 decomposition reaction Methods 0.000 claims description 8
- 239000003495 polar organic solvent Substances 0.000 claims description 8
- 239000011541 reaction mixture Substances 0.000 claims description 8
- 238000005119 centrifugation Methods 0.000 claims description 7
- 239000008394 flocculating agent Substances 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 6
- 150000001335 aliphatic alkanes Chemical class 0.000 claims description 6
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 claims description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 4
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 claims description 4
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 claims description 4
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical compound OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 claims description 4
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 4
- SNRUBQQJIBEYMU-UHFFFAOYSA-N dodecane Chemical compound CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 claims description 4
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 claims description 4
- CCCMONHAUSKTEQ-UHFFFAOYSA-N octadec-1-ene Chemical group CCCCCCCCCCCCCCCCC=C CCCMONHAUSKTEQ-UHFFFAOYSA-N 0.000 claims description 4
- 150000002576 ketones Chemical class 0.000 claims description 3
- 239000002077 nanosphere Substances 0.000 claims description 3
- 229960000541 cetyl alcohol Drugs 0.000 claims description 2
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 claims description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 2
- BUUPQKDIAURBJP-UHFFFAOYSA-N sulfinic acid Chemical compound OS=O BUUPQKDIAURBJP-UHFFFAOYSA-N 0.000 claims 1
- 125000003396 thiol group Chemical class [H]S* 0.000 claims 1
- 239000002159 nanocrystal Substances 0.000 abstract description 118
- 230000005291 magnetic effect Effects 0.000 abstract description 27
- 229910044991 metal oxide Inorganic materials 0.000 abstract description 27
- 150000004706 metal oxides Chemical class 0.000 abstract description 27
- 230000003287 optical effect Effects 0.000 abstract description 14
- 229910000314 transition metal oxide Inorganic materials 0.000 abstract description 14
- 239000002537 cosmetic Substances 0.000 abstract description 10
- 230000001965 increasing effect Effects 0.000 abstract description 7
- 239000012454 non-polar solvent Substances 0.000 abstract description 6
- 239000008194 pharmaceutical composition Substances 0.000 abstract description 6
- 125000000217 alkyl group Chemical group 0.000 abstract description 4
- AMWRITDGCCNYAT-UHFFFAOYSA-L hydroxy(oxo)manganese;manganese Chemical compound [Mn].O[Mn]=O.O[Mn]=O AMWRITDGCCNYAT-UHFFFAOYSA-L 0.000 description 141
- BERDEBHAJNAUOM-UHFFFAOYSA-N copper(I) oxide Inorganic materials [Cu]O[Cu] BERDEBHAJNAUOM-UHFFFAOYSA-N 0.000 description 68
- KRFJLUBVMFXRPN-UHFFFAOYSA-N cuprous oxide Chemical compound [O-2].[Cu+].[Cu+] KRFJLUBVMFXRPN-UHFFFAOYSA-N 0.000 description 53
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 51
- QPLDLSVMHZLSFG-UHFFFAOYSA-N Copper oxide Chemical compound [Cu]=O QPLDLSVMHZLSFG-UHFFFAOYSA-N 0.000 description 35
- 229910052751 metal Inorganic materials 0.000 description 35
- 239000002184 metal Substances 0.000 description 35
- 239000000463 material Substances 0.000 description 32
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 31
- 238000003917 TEM image Methods 0.000 description 31
- 239000010949 copper Substances 0.000 description 29
- 239000000243 solution Substances 0.000 description 28
- 238000000634 powder X-ray diffraction Methods 0.000 description 26
- 238000006243 chemical reaction Methods 0.000 description 22
- 239000000047 product Substances 0.000 description 22
- 238000009472 formulation Methods 0.000 description 16
- 239000010409 thin film Substances 0.000 description 16
- 238000003786 synthesis reaction Methods 0.000 description 15
- 239000013078 crystal Substances 0.000 description 14
- SZVJSHCCFOBDDC-UHFFFAOYSA-N ferrosoferric oxide Chemical compound O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 14
- 238000002360 preparation method Methods 0.000 description 12
- 238000000576 coating method Methods 0.000 description 11
- 239000003381 stabilizer Substances 0.000 description 11
- 239000011248 coating agent Substances 0.000 description 10
- 239000012071 phase Substances 0.000 description 10
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 9
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 9
- 238000004458 analytical method Methods 0.000 description 9
- 229910052802 copper Inorganic materials 0.000 description 9
- 230000012010 growth Effects 0.000 description 9
- 239000004094 surface-active agent Substances 0.000 description 9
- 230000008901 benefit Effects 0.000 description 8
- LBJNMUFDOHXDFG-UHFFFAOYSA-N copper;hydrate Chemical compound O.[Cu].[Cu] LBJNMUFDOHXDFG-UHFFFAOYSA-N 0.000 description 8
- 238000005516 engineering process Methods 0.000 description 8
- PVFSDGKDKFSOTB-UHFFFAOYSA-K iron(3+);triacetate Chemical compound [Fe+3].CC([O-])=O.CC([O-])=O.CC([O-])=O PVFSDGKDKFSOTB-UHFFFAOYSA-K 0.000 description 8
- 239000010410 layer Substances 0.000 description 8
- 239000011572 manganese Substances 0.000 description 8
- 229940071125 manganese acetate Drugs 0.000 description 8
- UOGMEBQRZBEZQT-UHFFFAOYSA-L manganese(2+);diacetate Chemical compound [Mn+2].CC([O-])=O.CC([O-])=O UOGMEBQRZBEZQT-UHFFFAOYSA-L 0.000 description 8
- 239000007858 starting material Substances 0.000 description 8
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 7
- 239000011651 chromium Substances 0.000 description 7
- 239000006185 dispersion Substances 0.000 description 7
- 238000010438 heat treatment Methods 0.000 description 7
- 239000004065 semiconductor Substances 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- 230000006641 stabilisation Effects 0.000 description 7
- 238000011105 stabilization Methods 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical group [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- 125000004429 atom Chemical group 0.000 description 6
- 238000012512 characterization method Methods 0.000 description 6
- 229960004643 cupric oxide Drugs 0.000 description 6
- 238000000151 deposition Methods 0.000 description 6
- 230000008021 deposition Effects 0.000 description 6
- 230000005684 electric field Effects 0.000 description 6
- 238000003384 imaging method Methods 0.000 description 6
- 239000006210 lotion Substances 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000013110 organic ligand Substances 0.000 description 6
- 239000007800 oxidant agent Substances 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 238000004098 selected area electron diffraction Methods 0.000 description 6
- 238000005979 thermal decomposition reaction Methods 0.000 description 6
- 239000010936 titanium Substances 0.000 description 6
- UYPYRKYUKCHHIB-UHFFFAOYSA-N trimethylamine N-oxide Chemical compound C[N+](C)(C)[O-] UYPYRKYUKCHHIB-UHFFFAOYSA-N 0.000 description 6
- 239000003981 vehicle Substances 0.000 description 6
- 239000005751 Copper oxide Substances 0.000 description 5
- 150000001735 carboxylic acids Chemical class 0.000 description 5
- 238000006555 catalytic reaction Methods 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 229910000431 copper oxide Inorganic materials 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- 238000001228 spectrum Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 150000003573 thiols Chemical class 0.000 description 5
- 238000002371 ultraviolet--visible spectrum Methods 0.000 description 5
- 229960000314 zinc acetate Drugs 0.000 description 5
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- 238000009792 diffusion process Methods 0.000 description 4
- 239000003085 diluting agent Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 229910052748 manganese Inorganic materials 0.000 description 4
- 229940031182 nanoparticles iron oxide Drugs 0.000 description 4
- 239000000546 pharmaceutical excipient Substances 0.000 description 4
- 235000011007 phosphoric acid Nutrition 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 230000000475 sunscreen effect Effects 0.000 description 4
- 239000000516 sunscreening agent Substances 0.000 description 4
- 230000007704 transition Effects 0.000 description 4
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 3
- 239000012691 Cu precursor Substances 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 3
- 206010051246 Photodermatosis Diseases 0.000 description 3
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 3
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 150000001242 acetic acid derivatives Chemical class 0.000 description 3
- 230000002776 aggregation Effects 0.000 description 3
- 125000001931 aliphatic group Chemical group 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 229910052804 chromium Inorganic materials 0.000 description 3
- 229910017052 cobalt Inorganic materials 0.000 description 3
- 239000010941 cobalt Substances 0.000 description 3
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 3
- 239000000084 colloidal system Substances 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- RFKZUAOAYVHBOY-UHFFFAOYSA-M copper(1+);acetate Chemical compound [Cu+].CC([O-])=O RFKZUAOAYVHBOY-UHFFFAOYSA-M 0.000 description 3
- OPQARKPSCNTWTJ-UHFFFAOYSA-L copper(ii) acetate Chemical compound [Cu+2].CC([O-])=O.CC([O-])=O OPQARKPSCNTWTJ-UHFFFAOYSA-L 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 229910052735 hafnium Inorganic materials 0.000 description 3
- VBJZVLUMGGDVMO-UHFFFAOYSA-N hafnium atom Chemical compound [Hf] VBJZVLUMGGDVMO-UHFFFAOYSA-N 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000314 lubricant Substances 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 229910052750 molybdenum Inorganic materials 0.000 description 3
- 239000011733 molybdenum Substances 0.000 description 3
- 229910052759 nickel Inorganic materials 0.000 description 3
- 238000010899 nucleation Methods 0.000 description 3
- 230000006911 nucleation Effects 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- 230000005693 optoelectronics Effects 0.000 description 3
- 239000012044 organic layer Substances 0.000 description 3
- 230000008845 photoaging Effects 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- 229910052707 ruthenium Inorganic materials 0.000 description 3
- 229910052706 scandium Inorganic materials 0.000 description 3
- SIXSYDAISGFNSX-UHFFFAOYSA-N scandium atom Chemical compound [Sc] SIXSYDAISGFNSX-UHFFFAOYSA-N 0.000 description 3
- VSZWPYCFIRKVQL-UHFFFAOYSA-N selanylidenegallium;selenium Chemical compound [Se].[Se]=[Ga].[Se]=[Ga] VSZWPYCFIRKVQL-UHFFFAOYSA-N 0.000 description 3
- 235000002639 sodium chloride Nutrition 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 230000002194 synthesizing effect Effects 0.000 description 3
- JBQYATWDVHIOAR-UHFFFAOYSA-N tellanylidenegermanium Chemical compound [Te]=[Ge] JBQYATWDVHIOAR-UHFFFAOYSA-N 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 229910052719 titanium Inorganic materials 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- 229910052723 transition metal Inorganic materials 0.000 description 3
- 238000004627 transmission electron microscopy Methods 0.000 description 3
- 229910052727 yttrium Inorganic materials 0.000 description 3
- VWQVUPCCIRVNHF-UHFFFAOYSA-N yttrium atom Chemical compound [Y] VWQVUPCCIRVNHF-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 238000005169 Debye-Scherrer Methods 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 238000002441 X-ray diffraction Methods 0.000 description 2
- 238000000862 absorption spectrum Methods 0.000 description 2
- 238000005054 agglomeration Methods 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 238000003491 array Methods 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000008499 blood brain barrier function Effects 0.000 description 2
- 210000001218 blood-brain barrier Anatomy 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 229940112669 cuprous oxide Drugs 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 239000002781 deodorant agent Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000010291 electrical method Methods 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 230000037308 hair color Effects 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 2
- 239000000696 magnetic material Substances 0.000 description 2
- 230000005389 magnetism Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000002086 nanomaterial Substances 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 125000004430 oxygen atom Chemical group O* 0.000 description 2
- 239000003973 paint Substances 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 230000008832 photodamage Effects 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000011819 refractory material Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000002453 shampoo Substances 0.000 description 2
- 150000003384 small molecules Chemical class 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000012916 structural analysis Methods 0.000 description 2
- 150000003624 transition metals Chemical class 0.000 description 2
- LEONUFNNVUYDNQ-UHFFFAOYSA-N vanadium atom Chemical compound [V] LEONUFNNVUYDNQ-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- BLSQLHNBWJLIBQ-OZXSUGGESA-N (2R,4S)-terconazole Chemical compound C1CN(C(C)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2N=CN=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 BLSQLHNBWJLIBQ-OZXSUGGESA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- QGLWBTPVKHMVHM-KTKRTIGZSA-N (z)-octadec-9-en-1-amine Chemical compound CCCCCCCC\C=C/CCCCCCCCN QGLWBTPVKHMVHM-KTKRTIGZSA-N 0.000 description 1
- NKJOXAZJBOMXID-UHFFFAOYSA-N 1,1'-Oxybisoctane Chemical compound CCCCCCCCOCCCCCCCC NKJOXAZJBOMXID-UHFFFAOYSA-N 0.000 description 1
- DPUOLQHDNGRHBS-UHFFFAOYSA-N Brassidinsaeure Natural products CCCCCCCCC=CCCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000238366 Cephalopoda Species 0.000 description 1
- JJHHIJFTHRNPIK-UHFFFAOYSA-N Diphenyl sulfoxide Chemical compound C=1C=CC=CC=1S(=O)C1=CC=CC=C1 JJHHIJFTHRNPIK-UHFFFAOYSA-N 0.000 description 1
- URXZXNYJPAJJOQ-UHFFFAOYSA-N Erucic acid Natural products CCCCCCC=CCCCCCCCCCCCC(O)=O URXZXNYJPAJJOQ-UHFFFAOYSA-N 0.000 description 1
- 239000012692 Fe precursor Substances 0.000 description 1
- 229910001218 Gallium arsenide Inorganic materials 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 229910001289 Manganese-zinc ferrite Inorganic materials 0.000 description 1
- 229910018388 Mn(CH3CO2)2 Inorganic materials 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 240000005428 Pistacia lentiscus Species 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000011398 Portland cement Substances 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- JIYIUPFAJUGHNL-UHFFFAOYSA-N [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[Mn++].[Mn++].[Mn++].[Fe+3].[Fe+3].[Fe+3].[Fe+3].[Fe+3].[Fe+3].[Fe+3].[Fe+3].[Fe+3].[Fe+3].[Zn++].[Zn++] Chemical compound [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[Mn++].[Mn++].[Mn++].[Fe+3].[Fe+3].[Fe+3].[Fe+3].[Fe+3].[Fe+3].[Fe+3].[Fe+3].[Fe+3].[Fe+3].[Zn++].[Zn++] JIYIUPFAJUGHNL-UHFFFAOYSA-N 0.000 description 1
- CPLPNZFTIJOEIN-UHFFFAOYSA-I [V+5].CC([O-])=O.CC([O-])=O.CC([O-])=O.CC([O-])=O.CC([O-])=O Chemical compound [V+5].CC([O-])=O.CC([O-])=O.CC([O-])=O.CC([O-])=O.CC([O-])=O CPLPNZFTIJOEIN-UHFFFAOYSA-I 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229940057499 anhydrous zinc acetate Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000002152 aqueous-organic solution Substances 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000013590 bulk material Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- UHYPYGJEEGLRJD-UHFFFAOYSA-N cadmium(2+);selenium(2-) Chemical compound [Se-2].[Cd+2] UHYPYGJEEGLRJD-UHFFFAOYSA-N 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012993 chemical processing Methods 0.000 description 1
- WYYQVWLEPYFFLP-UHFFFAOYSA-K chromium(3+);triacetate Chemical class [Cr+3].CC([O-])=O.CC([O-])=O.CC([O-])=O WYYQVWLEPYFFLP-UHFFFAOYSA-K 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 229910052681 coesite Inorganic materials 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000002153 concerted effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 229910052906 cristobalite Inorganic materials 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000007872 degassing Methods 0.000 description 1
- 230000005347 demagnetization Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical compound C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000007772 electrode material Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000000407 epitaxy Methods 0.000 description 1
- DPUOLQHDNGRHBS-KTKRTIGZSA-N erucic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-KTKRTIGZSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 230000005294 ferromagnetic effect Effects 0.000 description 1
- 239000003302 ferromagnetic material Substances 0.000 description 1
- 230000005307 ferromagnetism Effects 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000003063 flame retardant Substances 0.000 description 1
- 239000003546 flue gas Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000002189 fluorescence spectrum Methods 0.000 description 1
- NBVXSUQYWXRMNV-UHFFFAOYSA-N fluoromethane Chemical group FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 239000005003 food packaging material Substances 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 229940089256 fungistat Drugs 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000000024 high-resolution transmission electron micrograph Methods 0.000 description 1
- 238000002173 high-resolution transmission electron microscopy Methods 0.000 description 1
- 239000007970 homogeneous dispersion Substances 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- DOUHZFSGSXMPIE-UHFFFAOYSA-N hydroxidooxidosulfur(.) Chemical compound [O]SO DOUHZFSGSXMPIE-UHFFFAOYSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- LNOZJRCUHSPCDZ-UHFFFAOYSA-L iron(ii) acetate Chemical class [Fe+2].CC([O-])=O.CC([O-])=O LNOZJRCUHSPCDZ-UHFFFAOYSA-L 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 229910001416 lithium ion Inorganic materials 0.000 description 1
- 238000001748 luminescence spectrum Methods 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000006249 magnetic particle Substances 0.000 description 1
- 230000005415 magnetization Effects 0.000 description 1
- ZWXOQTHCXRZUJP-UHFFFAOYSA-N manganese(2+);manganese(3+);oxygen(2-) Chemical group [O-2].[O-2].[O-2].[O-2].[Mn+2].[Mn+3].[Mn+3] ZWXOQTHCXRZUJP-UHFFFAOYSA-N 0.000 description 1
- PPNAOCWZXJOHFK-UHFFFAOYSA-N manganese(2+);oxygen(2-) Chemical class [O-2].[Mn+2] PPNAOCWZXJOHFK-UHFFFAOYSA-N 0.000 description 1
- 239000008204 material by function Substances 0.000 description 1
- 239000002923 metal particle Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- TXCOQXKFOPSCPZ-UHFFFAOYSA-J molybdenum(4+);tetraacetate Chemical class [Mo+4].CC([O-])=O.CC([O-])=O.CC([O-])=O.CC([O-])=O TXCOQXKFOPSCPZ-UHFFFAOYSA-J 0.000 description 1
- 239000011858 nanopowder Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000011356 non-aqueous organic solvent Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- ACVYVLVWPXVTIT-UHFFFAOYSA-M phosphinate Chemical compound [O-][PH2]=O ACVYVLVWPXVTIT-UHFFFAOYSA-M 0.000 description 1
- 150000003009 phosphonic acids Chemical class 0.000 description 1
- 150000003016 phosphoric acids Chemical class 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 239000011253 protective coating Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- ILVXOBCQQYKLDS-UHFFFAOYSA-N pyridine N-oxide Chemical compound [O-][N+]1=CC=CC=C1 ILVXOBCQQYKLDS-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 239000000565 sealant Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 230000005476 size effect Effects 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000008174 sterile solution Substances 0.000 description 1
- 229910052682 stishovite Inorganic materials 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 150000003455 sulfinic acids Chemical class 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000002887 superconductor Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 150000003623 transition metal compounds Chemical class 0.000 description 1
- 229910021524 transition metal nanoparticle Inorganic materials 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 229910052905 tridymite Inorganic materials 0.000 description 1
- 229930195735 unsaturated hydrocarbon Natural products 0.000 description 1
- 239000002966 varnish Substances 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
- 238000007704 wet chemistry method Methods 0.000 description 1
- DJWUNCQRNNEAKC-UHFFFAOYSA-L zinc acetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O DJWUNCQRNNEAKC-UHFFFAOYSA-L 0.000 description 1
- 229910000859 α-Fe Inorganic materials 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B13/00—Oxygen; Ozone; Oxides or hydroxides in general
- C01B13/14—Methods for preparing oxides or hydroxides in general
- C01B13/18—Methods for preparing oxides or hydroxides in general by thermal decomposition of compounds, e.g. of salts or hydroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/27—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
- C01G1/00—Methods of preparing compounds of metals not covered by subclasses C01B, C01C, C01D, or C01F, in general
- C01G1/02—Oxides
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
- C01G3/00—Compounds of copper
- C01G3/02—Oxides; Hydroxides
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
- C01G45/00—Compounds of manganese
- C01G45/02—Oxides; Hydroxides
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
- C01G49/00—Compounds of iron
- C01G49/02—Oxides; Hydroxides
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
- C01G49/00—Compounds of iron
- C01G49/02—Oxides; Hydroxides
- C01G49/04—Ferrous oxide [FeO]
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
- C01G49/00—Compounds of iron
- C01G49/02—Oxides; Hydroxides
- C01G49/06—Ferric oxide [Fe2O3]
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
- C01G49/00—Compounds of iron
- C01G49/02—Oxides; Hydroxides
- C01G49/08—Ferroso-ferric oxide [Fe3O4]
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
- C01G9/00—Compounds of zinc
- C01G9/02—Oxides; Hydroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/413—Nanosized, i.e. having sizes below 100 nm
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/12—Face or body powders for grooming, adorning or absorbing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q13/00—Formulations or additives for perfume preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/10—Preparations for permanently dyeing the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/12—Preparations containing hair conditioners
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2002/00—Crystal-structural characteristics
- C01P2002/70—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2002/00—Crystal-structural characteristics
- C01P2002/70—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data
- C01P2002/72—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data by d-values or two theta-values, e.g. as X-ray diagram
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2002/00—Crystal-structural characteristics
- C01P2002/70—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data
- C01P2002/76—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data by a space-group or by other symmetry indications
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2002/00—Crystal-structural characteristics
- C01P2002/70—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data
- C01P2002/77—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data by unit-cell parameters, atom positions or structure diagrams
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2002/00—Crystal-structural characteristics
- C01P2002/80—Crystal-structural characteristics defined by measured data other than those specified in group C01P2002/70
- C01P2002/82—Crystal-structural characteristics defined by measured data other than those specified in group C01P2002/70 by IR- or Raman-data
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/01—Particle morphology depicted by an image
- C01P2004/03—Particle morphology depicted by an image obtained by SEM
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/01—Particle morphology depicted by an image
- C01P2004/04—Particle morphology depicted by an image obtained by TEM, STEM, STM or AFM
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/51—Particles with a specific particle size distribution
- C01P2004/52—Particles with a specific particle size distribution highly monodisperse size distribution
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/60—Particles characterised by their size
- C01P2004/64—Nanometer sized, i.e. from 1-100 nanometer
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2006/00—Physical properties of inorganic compounds
- C01P2006/42—Magnetic properties
Definitions
- the United States Government may have certain rights in the present invention pursuant to partial funding by grants from the Materials Research Science and Engineering Center (DMR-0213574 MRSEC) and the Nanoscale Science and Engineering Center (CHE-0117752 NSEC) of the National Science Foundation and pursuant to partial funding by the U.S. Department of Energy, Office of Basic Energy Sciences, through the Catalysis Futures grant DE-FG02-03ER15463, and in part by the (i) the MRSEC program of the National Science Foundation under award number DMR-0213574, and NSF-CAREER award, DMR-0348938.
- DMR-0213574 MRSEC Materials Research Science and Engineering Center
- CHE-0117752 NSEC Nanoscale Science and Engineering Center
- the present invention relates generally to nanoparticles of transition metals, e.g., nanocrystals, their synthesis and characterization. More particularly, the invention relates to the synthesis of metal oxide nanoparticles that are monodisperse, uniform in size and stable. The nanoparticles of the present invention are safer and more environmentally benign than those prepared by previously described methods.
- Nanocrystals typically have a diameter of between 1 and 100 nm and may contain as few as a hundred or as many as tens of thousands of atoms having size-dependent properties and the possibility of arrangement in micro (and nano) assemblies. Nanocrystals have become the focus of intensive research due to their numerous applications in diverse fields such as catalyst production, ultramodern electronic and electrooptical devices, supermagnets, photographic suspensions, etc.
- nanometer sized materials The development, characterization and exploitation of nanometer sized materials is an exceptionally active and rapidly expanding field.
- the exploration of complex structures on the nanometer size scale is underway in a variety of disciplines, such as chemistry, physics and engineering.
- the importance of such new interdisciplinary studies may be realized in the design and characterization of advanced materials.
- Studies of nanometer sized semiconductors, metals and refractories (nanoceramics) provide powerful examples of how control of particle size can optimize material performance.
- nanoparticles such as metal oxide-based nanoparticles (also referred to as nanocrystals herein).
- the methods are economical and efficient, particularly due to the ready availability of starting material or metal precursors used in the methods.
- high-quality nanoparticles are formed having the characteristics of uniform size, monodispersity, stability (i.e., lack of degradation due, for example, to oxidation) as well as stability in non-polar solvents due to the presence of one or more non-polar capping groups at the surface, and magnetic properties.
- the methods are suitable for obtaining metal-based nanoparticles, particularly transition metal oxides, including for example and without limitation, zinc (Zn), iron (Fe), manganese (Mn), cobalt (Co), ruthenium (Ru), copper (Cu), scandium (Sc), titanium (Ti), vanadium (V), chromium (Cr), molybdenum (Mo), yttrium (Y), zirconium (Zr), hafnium (Hf), and nickel (Ni) metal-based nanoparticles.
- transition metal oxides including for example and without limitation, zinc (Zn), iron (Fe), manganese (Mn), cobalt (Co), ruthenium (Ru), copper (Cu), scandium (Sc), titanium (Ti), vanadium (V), chromium (Cr), molybdenum (Mo), yttrium (Y), zirconium (Zr), hafnium (Hf), and nickel (Ni) metal-based nanoparticles.
- a non-hydrolytic synthetic method is provided for effectively tailoring a uniform particle size and controlling the homogeneous dispersion of ultrafine metal oxide nanocrystals, e.g., iron oxide nanocrystals, zinc oxide nanocrystals and manganese oxide nanocrystals.
- Magnetic nanocrystals, and uses thereof, of metal oxides, e.g., manganese oxide provide a particular aspect of this invention.
- the method involves a non-aqueous environment, e.g., hydrocarbon-based solvents, in which anhydrous acetate precursors of a given metal are used.
- a metal acetate starting material or precursor in such a solvent environment is a unique aspect of the present invention.
- the method further involves heating the metal acetate precursors, which are readily available and inexpensive, to a high temperature, e.g., greater than about 100° C.
- the metal acetate is then decomposed at high temperature in the presence of an organic solvent, e.g., trialkylamine, comprising at least one organic stabilizing ligand (also referred to as an organic stabilizer or organic ligand), e.g., oleic acid.
- an organic solvent e.g., trialkylamine
- organic stabilizing ligand also referred to as an organic stabilizer or organic ligand
- the metal oxide nanoparticles are extracted at a temperature lower than that of the reaction temperature, e.g., room temperature, using a flocculating agent, e.g., a polar organic solvent, to precipitate the metal oxide nanoparticles into hydrocarbon solvent, such as an alkane.
- a flocculating agent e.g., a polar organic solvent
- the metal oxide nanocrystals resulting from the methods of the invention are monodisperse, of uniform size, and are enclosed (packaged) in an organic outside layer or coating (e.g., ligand capped).
- Particular monodisperse metal oxide nanoparticles produced by the present methods include, without limitation, zinc oxide nanoparticles, manganese oxide nanoparticles, iron oxide nanoparticles and cupric oxide nanoparticles.
- the present invention provides a method of producing uniformed sized nanoparticles having useful properties, such as light reflecting and absorbing properties for use in preventative or therapeutic products and formulations to prevent, reduce, retard, ameliorate, or eliminate photodamage and/or photoaging in a human or animal due to exposure to sunlight.
- useful properties such as light reflecting and absorbing properties
- Such products and formulations are useful as sunscreens, suntan lotions and sunblocks. and as components thereof.
- the nanoparticles also may have magnetic properties, which are significantly different from the bulk material and which enhance their use in magnetic recording media, and read and write heads, as well as in a number of imaging, optical and electrical methods and devices.
- the nanoparticles find use in the area of electrical field deposition technology for thin films, and in laser technology for use in laser materials.
- the nanoparticles have a significant grain size. Control of grain size is important in being able to tune the properties of a specific material for a particular application.
- semiconducting materials such as cadmium selenide, have a tunable bandgap energy as a function of size in the nanoscale regime which gives rise to tunable optical properties.
- Their outer organic layer or coating, uniform size and composition should allow the nanoparticles to cross the blood brain barrier, thus affording materials for formulating into useful compositions, e.g., drugs, small molecules, for medical and pharmaceutical uses.
- the properties of the nanoparticles prepared by the methods of this invention provide further commercially applicable utility for these materials in a variety of products such as many types of cosmetics, polymers, plastics, paints, and a variety of other industrial products and formulations.
- Other examples of applications of the nanoparticles prepared by the methods of this invention include skin products, drug delivery vehicles, and MRI contrast enhancement agents.
- the present invention provides compositions comprising the monodisperse and stable nanoparticles for use in cosmetics and pharmaceutical compositions.
- a pharmaceutically or physiologically acceptable carrier, diluent, excipient, or vehicle is further included.
- Yet another aspect of the present invention provides efficient and inexpensive methods for synthesizing nanoparticles, in particular, specific transition metal oxide nanoparticles, such as iron oxide, manganese oxide, and zinc oxide, in which the method comprises treating a metal acetate precursor under anhydrous conditions in the presence of organic solvent, e.g., trialkylamine, and at least one organic stabilizing ligand, e.g., oleic acid, and at temperature of from about 100° C.-150° C., and decomposing the metal acetate to produce metal oxide nanoparticles of uniform crystal size.
- organic solvent e.g., trialkylamine
- organic stabilizing ligand e.g., oleic acid
- a further aspect of the present invention provides high quality monodisperse, uniformly-sized nanoparticles, which are stable; resist degradation, e.g., via oxidation or nonpolar solvents; are encased or packaged in an outer organic layer or coating; and which result from the practice of the described methods.
- the nanoparticles can be magnetic and can comprise thin films.
- a composition comprising the nanoparticles of the invention can be used for the preparation of magnetic recording media, read and write heads, imaging devices or components thereof (including contrast enhancement agents in MRI imaging and/or other biomedical imaging applications), electrical field deposition devices or components thereof, magnetic devices or components thereof, optical devices or components thereof, or thin films.
- Such nanoparticles can be employed in a variety of applications, including those described hereinabove.
- the present invention involves a method of synthesizing iron oxide (FeO) nanoparticles of uniform size and monodispersity comprising subjecting iron acetate starting material to a temperature of from about 200° C. to about 260° C., preferably about 250° C., in an organic solvent, e.g., trialkylamine, in the presence of oleic acid to produce iron oxide nanocrystals having the desired properties following decomposition of the iron acetate and precipitation of the FeO nanocrystals with a flocculent, e.g., a polar organic solvent, into hydrocarbon solvent under conditions of a temperature lower than the reaction temperature used with the iron acetate, e.g., room temperature, or 100° C. or lower.
- a flocculent e.g., a polar organic solvent
- the present invention involves a method of synthesizing monodispersed and uniform manganese oxide, i.e., MnO and Mn 3 O 4 , nanoparticles comprising subjecting manganese acetate starting material to a temperature of from about 300° C.
- Mn 3 O 4 nanocrystals can be prepared by oxidation of the MnO nanoparticles, e.g., by natural oxidation of MnO in air; such Mn 3 O 4 nanocrystals have magnetic properties, e.g., ferromagnetic properties.
- the Mn 3 O 4 nanocrystals synthesized in accordance with this invention provide a magnetic material having magnetic properties and applications.
- a Mn 3 O 4 /Fe 3 O 4 superlattice comprising the Mn 3 O 4 nanocrystals provides a magnet.
- a superlattice thin film comprising Mn 3 O 4 /Fe 3 O 4 is further provided by the invention.
- magnetoresistive material, involving magnetoresistive oxide thin films can be produced using electrical field deposition technology, which is a technique practiced in the art.
- FIGS. 1A and 1B show the crystalline characteristics of MnO nanocrystals prepared according to the present invention.
- FIG. 1A shows X-ray powder diffraction (XRD) patterns of 7 nm diameter MnO nanocrystals exhibiting the highly crystalline peaks that can be matched to the series of Bragg reflections corresponding to the standard and phase pure cubic rock salt structure of MnO.
- FIG. 1B shows the indexed selected area electron diffraction patterns (SAED) of the MnO nanocrystals formed by the methods of the invention and having the XRD patterns shown in FIG. 1A .
- SAED selected area electron diffraction patterns
- FIGS. 2A-2F show transmission electron micrographs (TEM) of monodispersed nanoparticles of MnO prepared as described according to the present methods.
- FIG. 2A shows a TEM of MnO nanoparticles of 6-7 nm. (50 nm scale).
- FIG. 2B shows a TEM of MnO nanoparticles of 14 nm. (70 nm scale).
- FIG. 2C shows a TEM of MnO nanoparticles of 16 nm. (125 nm scale).
- FIG. 2D shows a TEM of MnO nanoparticles of 20 nm. (150 nm scale).
- FIG. 2E shows a TEM of 16 nm MnO nanoparticles having cubic structure. (30 nm scale).
- FIG. 2F shows that quality superlattice structures are formed from the MnO nanoparticles synthesized according to the present methods and viewed by TEM. (100 nm scale).
- FIGS. 3A-3C show properties of Mn 3 O 4 nanocrystals prepared according to the present methods by further oxidation of MnO.
- FIG. 3A shows a TEM of uniformly sized 6-7 nm Mn 3 O 4 nanocrystals, which were oxidized naturally in air. (100 nm scale).
- FIG. 3B shows the XRD analysis of the Mn 3 O 4 nanoparticles of FIG. 3A , prepared by the present methods.
- FIG. 3C shows the indexed SAED analysis of the Mn 3 O 4 nanoparticles analyzed in FIG. 3B .
- FIGS. 4A-4E depict the results of magnetic studies performed on MnO nanoparticles produced by the methods of the present invention. More specifically these figures depict analyses of the magnetic properties of the 14 nm MnO nanoparticles.
- FIG. 4A shows the results of a Super-conducting Quantum Interference Device (SQUID) analysis of magnitization versus temperature of the MnO nanoparticles. SQUIDs are used to measure the magnetic properties of materials at low temperature.
- FIGS. 4B-4E (2K, 5K, 20K and 30K, respectively) show hysteresis studies of the MnO nanoparticles at different temperatures.
- FIGS. 4F-4L depict analyses of the magnetic properties of Mn 3 O 4 nanoparticles.
- FIGS. 4G-4L (2K, 5K, 10K, 20K, 40K and 50K, respectively) show hysteresis studies of the 14 nm Mn 3 O 4 nanoparticles at different temperatures.
- FIGS. 5A-5E show characteristics of ZnO nanoparticles synthesized by the methods of the present invention.
- FIGS. 5A (100 nm scale) and 5 B (80 nm scale) show TEM analyses of ZnO nanorods (2-3 nm ⁇ 30-40 nm) produced by the present methods.
- FIGS. 5C and 5D show a SAED analysis of the ZnO nanorods (2-3 nm ⁇ 30-40 nm) produced by the methods.
- FIG. 5E shows an Ultraviolet-Visible Spectrum (UV-vis) of the ZnO nanorods produced by the present methods. The UV-vis shows the absorption profile in this part of the electromagnetic spectrum, thus elucidating the nanocrystals' interaction with light.
- UV-vis Ultraviolet-Visible Spectrum
- FIGS. 6A and 6B relate to evaluations of particle size of MnO nanocrystals prepared according to the methods of the present invention.
- FIG. 6A shows the average diameter of MnO nanocrystals as a function of growth over time at 100° C.
- FIG. 6B shows the data of FIG. 6A replotted as the particle diameter cubed versus the growth time, in accordance with the LSW model as described in Example 1.
- FIGS. 7A-7E relate to the characteristics of FeOm (13 nm) nanoparticles produced according to the methods of this invention. More particularly, FIG. 7A shows a TEM of the FeO nanoparticles at 300 nm scale; FIG. 7B shows a TEM of the FeO nanoparticles at 200 nm scale; FIG. 7C shows a TEM of the FeO nanoparticles at 100 nm scale; FIG. 7D shows a TEM of the FeO nanoparticles at 500 nm scale; and FIG. 7E shows an XRD of the 13 nm FeO nanoparticles produced by the present methods.
- FIGS. 8A and 8B further relate to zinc oxide (ZnO) nanoparticles in the form of nanorods produced according to the methods of the present invention.
- FIG. 8A shows an XRD of the ZnO nanorods; and
- FIG. 8B shows a TEM of the ZnO nanorods (100 nm scale).
- FIGS. 9A-9G relate to copper oxide (Cu 2 O) nanoparticles produced according to the methods of the present invention.
- FIG. 9A shows the results of XRD analyses of 2 nm, 4 nm and 6 nm Cu 2 O nanoparticles produced by the methods of the present invention.
- FIGS. 9B-9E show TEM images of monodisperse Cu 2 O nanoparticles at various magnifications, namely at scales of 75 nm, 150 nm, 50 nm and 20 nm, respectively.
- FIGS. 9F and 9G show TEM images of a Cu 2 O nanocrystal superlattice (10 nm scale and 15 nm scale, respectively).
- FIGS. 10A-10B illustrate ( FIG. 10A ) X-ray powder diffraction patterns of 5 nm fcc Cu nanocrystals, 10 minutes after synthesis and extraction from solution and ( FIG. 10B ) X-ray powder diffraction patterns of 5 nm cuprite Cu 2 O nanocrystals, sample prepared after oxidation.
- FIG. 11 illustrates a synthetic procedure for Cu 2 O nanocrystals.
- FIGS. 12A-12C show transmission electron micrograph (TEM) of self-assembled 6 nm diameter Cu 2 O Nanocrystals ( FIG. 12A ); TEM image showing a larger area view of a close-packed superlattice of 6 nm Cu 2 O nanocrystals (FIG. 12 B) and high resolution image showing the single crystal and high crystallinity ( FIG. 12C ).
- FIG. 12 D shows a selected area electron diffraction pattern of Cu 2 O nanocrystals.
- FIG. 13 shows UV-vis spectrum of as-prepared Cu 2 O nanocrystals in hexane at 298 K.
- FIGS. 14A-14B show transmission electron micrograph of 5.1 ⁇ 0.5 nm diameter Cu nanocrystal ( FIG. 14A ) and corresponding 6.1 ⁇ 0.9 nm diameter Cu 2 O nanocrystal ( FIG. 14B ), showing a 19.6% volume increase after oxidation; insert: Selected area electron diffraction pattern.
- FIG. 15 shows a plot of particle size vs the relative amount of oleic acid to copper (I) acetate, showing the diameter of the final product increases with a increased OA:Cu(Ac) 2 ratio.
- FIG. 16 shows a stick and ball model of the crystal structure of cuprite Cu 2 O.
- the present invention relates to methods of preparing nanoparticles (also referred to as nanocrystals herein) having size dependent nanocrystallite properties, including uniform size, monodispersity and stability over time, particularly in air and in nonpolar solvents. Magnetism is a further property possessed by a number of the nanoparticles of the present invention.
- This invention provides new synthetic routes to a prepare homologous sized series of monodisperse nanocrystals, which are monodisperse in terms of size, shape, internal structure and surface chemistry.
- the invention provides nanoparticles formed by the methods for use in a variety of different applications as described herein.
- nanoclaystal refers specifically to a crystalline nanoparticle, comprising an inorganic core of a single crystal of nanometer dimensions.
- the present invention encompasses both crystalline and non-crystalline metal oxide nanoparticles.
- the methods of the invention are particularly advantageous for producing nanoparticle products that are crystalline.
- Optical, electrical and magnetic studies of well-defined nanocrystal samples reveal the unique size-dependent properties of materials in this intermediate, nanometer size regime between molecular species and bulk solid.
- the present invention encompasses a newly-developed transition metal oxide system to produce nanostructured materials by virtue of a concerted synthetic, spectroscopic, and structural investigation. Methods for the preparation and systematic characterization of high quality nanocrystalline systems are provided. To distinguish true size dependent evolution from simple sample inhomogeneities and defects, a series of homologous samples spanning the size range of interest were produced as is described herein. When samples are nearly monodispersed, the ensemble average of the properties observed is representative of the properties of each individual crystallite. Thus, samples have been systematically synthesized and characterized using a combination of chemical and structural probes.
- One embodiment of this invention embraces a non-aqueous method for the synthesis of metal based nanoparticles, in particular, transition metal oxide nanoparticles.
- Suitable metal-based nanoparticles include, without limitation, zinc (Zn), iron (Fe), manganese (Mn), cobalt (Co), ruthenium (Ru), copper (Cu), scandium (Sc), titanium (Ti), vanadium (V), chromium (Cr), molybdenum (Mo), yttrium (Y), zirconium (Zr), hafnium (Hf), or nickel (Ni) metal-based nanoparticles, and mixtures thereof.
- these nanoparticles are capped with organic ligands.
- metal oxides prepared by the present methods include manganese oxide (MnO), iron oxide (FeO) and zinc oxide (ZnO), as well as more highly oxidized forms of one or more of these metal oxide nanoparticles.
- the nanoparticles produced by the methods are relatively monodisperse, or uniform in size. Accordingly, the monodisperse nanoparticles of the invention are within less than 10% root mean square deviation (rms) diameter for spherical nanoparticles and less than 10% rms length or width for nanoparticle cubes and rods.
- the nanoparticles are also of the same shape—either all spheres, or cubes, or rods.
- the nanoparticles that can be made using the present methods include, but are not limited to nanorods, nanospheres, nanocubes, nanotriangles, nanobipods, nanotripods and nanotetrapods.
- the size, e.g., diameter, of the nanoparticles produced in accordance with the present invention can range from between about 2 nm and about 50 nm, or from about 3 nm to about 25 nm, or from about 6 nm to about 20 nm.
- Nanoparticle size can be achieved by controlling reaction parameters and/or conditions, as necessary or desired.
- reaction parameters and/or conditions that may be controlled to achieve nanoparticles of different sizes include temperature, temperature heating and cooling rates, concentration of products, including solvent, ligand and metal precursor, heating and cooling times, and in particular, the time allowed for nanocrystal growth and the ratio of organic ligand to precursor.
- the nanoparticles generated according to the present methods are stable indefinitely under N 2 and are stable in air for periods of several months.
- a unique feature and advantage of the present methods is the use of simple metal acetate precursors to prepare ligand-capped transition metal nanoparticles, e.g., MnO, FeO and ZnO, which are safer and more environmentally benign than are nanoparticles prepared from metal carbonyl materials.
- Other advantages afforded by the synthetic procedures for fabricating metal oxide nanoparticles according to the present invention include the following. First, the method is simple and reproducible, with typical yields of over 80%. Second, highly crystalline and monodisperse nanoparticles are obtained directly from the method without further size selection.
- a beneficial aspect of the present methods is that monodisperse nanoparticles are generated through its practice without a need for further manipulation, selection, or size-selective precipitations based on size.
- Such direct production of useful and high quality nanoparticles is another advantage afforded by the present invention.
- particle size can be easily and fractionally increased by the present methods, thus allowing kinetic studies.
- thermodynamics of the methods of the present invention and the reactions therein result in a separation of crystal nucleation from nanocrystal growth.
- all nanocrystals start to grow at the same time, spontaneously and homogeneously, resulting directly in substantially monodispersed and stable nanoparticles of uniform size.
- the metal acetate precursor is anhydrous.
- the methods of the present invention provide the formation of virtually uniform sized nanoparticles having useful properties, such as light reflecting and absorbing properties for use in preventative or therapeutic products and formulations to prevent, reduce, retard, ameliorate, or eliminate photodamage and/or photoaging in a human or animal due to exposure to sunlight, such as in sunscreen formulations or compositions, suntan lotions or formulations and sunblock formulations or compositions.
- the nanoparticles also can have magnetic properties, which enhance their use in magnetic recording media, and read and write heads, as well as in a number of imaging and optical and electrical methods and devices.
- the nanoparticles find use in the area of electrical field deposition technology for thin films, and in laser technology for laser materials.
- the nanoparticles according to the present invention are uniform in phase (crystal structure) and are coated with a surface passivating layer of organic molecules.
- the outer organic layer or coating, uniform size and composition allow the nanoparticles to cross the blood brain barrier, thus affording materials for formulating into biomedically-related useful therapeutic and/or preventive compositions, e.g., drugs and small molecules, for medical, dental and pharmaceutical uses.
- Such compositions can address a need in medicine and related arts to access medically and biologically important areas that are presently difficult to access.
- the nanoparticles comprise compositions, which typically further include a pharmaceutically or physiologically acceptable carrier, diluent, vehicle, or excipient, such as physiologically sterile saline, or other physiologically acceptable injectable aqueous liquids, and the like.
- a pharmaceutically or physiologically acceptable carrier such as physiologically sterile saline, or other physiologically acceptable injectable aqueous liquids, and the like.
- compositions may include, without limitation, makeups, skin and body care products, such as topically-applied skin and body care products, soaps, powders, lotions, creams, ointments, conditioners, shampoos, fragrances, sunscreens, sunblocks, suntanning lotions, deodorants, deodorizers, hair colors and dyes.
- Topically applied and/or used products and product formulations are advantageously prepared.
- ZnO nanoparticles can impart special features to a variety of cosmetic preparations for care of the hair and skin.
- ZnO nanoparticles can protect the skin by absorbing ultraviolet radiation that can lead to photoaging and skin damage; in burn ointments ZnO nanoparticles can aid healing.
- zinc oxide nanoparticles find utility in numerous applications in various industries. Some of all of these utilities also apply to others of the metal oxide nanoparticles according to this invention.
- zinc oxide nanoparticles are useful in the rubber industry, such as in the particular areas of activation, acceleration, biochemical activity, dielectric strength, heat stabilization, latex gelation, light stabilization, pigmentation, reinforcement, rubber-metal bonding and tack retention.
- metal oxides in particular zinc oxide, is useful in aspects of the plastics industry; in adhesives, mastics and sealants; in lubricants, such as in extreme-pressure lubricants, seizure-resistant lubricants, and greases; in photocopying processes, in which the presence of ZnO nanoparticles may result in increased photoconductivity and semiconductor properties by special heat and/or doping treatments (addition of foreign elements).
- ZnO nanoparticles may be greatly modified in optical properties to increase the absorption of light rays in the visible region, a process known as sensitization, which is generally carried out by addition to certain dyes, which are absorbed on the surface of ZnO nanoparticles.
- metal oxide nanoparticles such as ZnO nanoparticles of the present invention
- anti-corrosive properties in metal protective coatings include anti-corrosive properties in metal protective coatings, cigarette filters to remove selected ingredients from tobacco smoke; sulfur removal from certain fluids and gases, such as industrial flue gases; foods and food packaging materials, e.g., incorporation into the varnish linings of metal containers to prevent discoloration from food; flame retardants; ferromagnetic materials for electronic, television, radio, and tele-communication applications; batteries, fuel cells, photocells, thermoelements; components in silicate compositions to form waterproof, fireproof refractory materials, as a fungistat in fungicides to increase their effectiveness in certain formulations; and as a component of Portland cement involved in retardation of setting and hardening (to reduce the rate of heat evolution) and in improvement in whiteness and final strength of the cement product.
- the present invention generally embraces a method of preparing monodisperse and stable metal oxide nanoparticles non-hydrolytically.
- the method comprises mixing a metal acetate precursor with a non-aqueous organic solvent comprising at least one organic stabilizer, or organic stabilizing ligand, to form a reaction mixture; heating the mixture at a temperature of greater than about 100° C., or at a temperature of from about 150° C. to about 450° C., or at a temperature of from about 150° C. to about 400° C., or at a temperature of from about 200° C. to about 380° C., or at a temperature of from about 250° C. to about 360° C., or at a temperature of from about 320° C.
- the reaction mixture is heated to the desired elevated temperature over a time period of from about 10 minutes to about 30 minutes, or from about 10 minutes to about 15 minutes, and the reaction is maintained at the elevated temperature for about 1 hour.
- the nanoparticles are then extracted into a hydrocarbon solvent under a cooler temperature, e.g., about 100° C. or less, typically at room temperature, e.g., from about 25° C. to about 60° C., by precipitation in a polar organic solvent, such as alcohols or ketones, also commonly referred to as flocculating agents or flocculents.
- the metal acetate precursor is anhydrous.
- particles of different diameters can be obtained by first subjecting the organic solution to the elevated temperature as described, which results in obtaining a specific nanoparticle diameter, e.g., from about 4 nm to about 10 nm. This is followed by subjecting the organic solution comprising the nanoparticles to a second lower temperature of from about 100° C. to about 150° C., for a period of from about 5 minutes to about 60 minutes. At the second lowered temperature, nanoparticles of larger specific diameters, e.g., from about 10 nm to about 40 nm, are obtained. Accordingly, nanocrystals with increased diameter, e.g., as determined by TEM, can be obtained over time at the lower temperature. In one embodiment, the second lower temperature is about 100° C.
- An advantage of the methods of the invention is that the resulting metal oxide nanocrystals are coated with an organic material, e.g., an organic ligand, also referred to as ligand capping.
- the organic coating consists of organic molecules that act as capping agents for the surface, which is beneficial for their subsequent uses in a variety of applications, such as, for example, pharmaceutical compositions, cosmetics, and the like.
- the transition metal oxide nanocrystals formed by the methods of the present invention are safer and more environmentally benign than their metal carbonyl counterparts.
- reaction of a transition metal acetate in the organic solvent is believed to proceed via thermal decomposition of the acetate to a metal oxide-oleic acid complex, with the formation of CO 2 and acetone by-products, aided by the elevated temperature.
- the metal acetate precursor can include, without limitation, zinc (Zn) acetate, iron (Fe) acetate, manganese (Mn) acetate, cobalt (Co) acetate, ruthenium (Ru), copper (Cu) acetate, scandium (Sc) acetate, titanium (Ti) acetate, vanadium (V) acetate, chromium (Cr) acetate, chromium acetate dimer, molybdenum (Mo) acetate, molybdenum acetate dimer, yttrium (Y) acetate, zirconium (Zr) acetate, hafnium (Hf) acetate, nickel (Ni) acetate, or mixtures thereof.
- the metal acetate precursor is mixed with an organic solvent, which comprises at least one organic stabilizing ligand, which can have surfactant properties.
- the metal acetate precursor is anhydr
- the organic solvent used in the present methods is typically unreactive with respect to the formation of the nanoparticles, and has a boiling point of from about 150° C. to about 400° C.
- any suitable solvent having a boiling point at the elevated temperatures as described herein and good solubility of the metal acetate precursor starting materials can be used.
- other solvents include mineral oil, paraffin wax and polyethylene glycol.
- Alkylamine and ether (e.g., phenylether or n-dioctylether) solvents are used; an exemplary solvent for use is a trialkylamine.
- Trialkylphosphines can also be used.
- Trialkylamine solvents for use in the present methods have the formula [CH 3 (CH 2 ) n ] 3 N, where n is an integer ranging from 4 to 12. Typically trioctylamine, having the formula [CH 3 (CH 2 ) 7 ] 3 N, is used.
- trialkylamines function as solvent in the methods of the present invention, rather than serving as both solvent and stabilizing ligand.
- the solvent trialkylamines do not interfere with the reaction chemistry that leads to the formation of monodisperse, uniform nanoparticles.
- the solvents per se are not directly involved in the formation of nanocrystals in the present methods.
- the organic solvent employed in the methods comprises one or more organic stabilizing agent or organic ligand.
- the one or more organic stabilizing ligands may also function as stabilizing agents.
- Suitable organic stabilizing ligands for use in the methods of this invention can be any long chain alkyl with one or more carboxylic acid functional group(s). These ligands typically have the formula C x H y [CO 2 H] z for integers x, y, and z that yield real saturated or unsaturated hydrocarbon chain carboxylic acid molecules, wherein x is an integer ranging from 6 to 30; z is an integer ranging from 1 to 3; and y is an integer ranging from 8 to 59.
- Organic ligands can include, for example, long chain organic compounds expressed in the form R—X, in which “R” comprises either a straight or branched hydrocarbon or fluorocarbon chain having from 6 to 25 carbon atoms or 8 to 22 carbon atoms; and “X” comprises a moiety (“X”) which provides specific chemical attachment to the nanoparticle surface.
- Illustrative active groups include, without limitation, sulfonate (—SO 2 OH), sulfinate (—SOOH), phosphinate (—POOH), phosphorate (—OPO(OH) 2 ), carboxylate, and thiol.
- the resulting stabilizers include sulfonic acids (R—SO 2 OH), sulfinic acids (R—SOON), phosphonic acids (R 2 POOH), phosphoric acids (R—OPO(OH) 2 ), carboxylic acids (R—COOH), thiols (R—SH), and mixtures thereof.
- the organic stabilizer is a carboxylic acid.
- the organic stabilizer is oleic acid.
- Oleic acid is known in the art as a surfactant stabilizer of colloids and has been used to protect iron nanoparticles. Oleic acid comprises a chain of 18 carbon atoms and is about 20 angstroms in length; it is not aliphatic and contains one double bond. The relatively long chain of oleic acid provides a major steric barrier to counteract the strong magnetic interaction between the particles. Oleic acid is advantageously used because it is inexpensive and easily available from natural sources, such as olive oil.
- Similar long chain carboxylic acids such as erucic acid and linoleic acid, (e.g., any long chain organic acid with between 6 and 22 carbon atoms may be used alone or in combination) can also be used, in addition to, or instead of, oleic acid.
- oleic acid and oleylamine ligands surround the resulting nanoparticles; these ligands can be replaced, or added to, by other aliphatic acids and primary amines, as necessary or desired.
- a typical reaction involves the mixing of metal acetate and organic solvent containing at least one organic stabilizing agent as described above.
- the resulting mixture is heated rapidly, for a period of from about 10 minutes to about 30 minutes. In one embodiment, the mixture is heated for a period of from about 10 minutes to about 15 minutes.
- the solution is maintained at the elevated temperature for at least about 45 minutes, or about 1 hour, and typically under N 2 flow, to yield uniform MnO nanocrystals. The method produces yields up to 80%.
- the nanocrystals are extracted at a lower temperature, e.g., from about 25° C. to about 60° C., into a hydrocarbon solvent, such as an alkane, including, but not limited to pentane, hexane, heptane, octane and dodecane, in particular, hexane, by precipitation in a polar organic solvent such as alcohols, e.g., methanol, ethanol, propanol, and butanol, or ketones, also referred to as flocculating agents (or flocculents). This is followed by centrifugation and redispersion in a hydrocarbon solvent, such as those mentioned above, e.g., hexane.
- a hydrocarbon solvent such as an alkane, including, but not limited to pentane, hexane, heptane, octane and dodecane, in particular, hexane
- Ethanol is a suitable precipitating agent.
- the nanocrystals resulting from the method are characterized using transmission electron microscopy (TEM) and X-ray powder diffraction (XRD), e.g., as described in Example 1 and shown in FIGS. 1A and 1B and FIGS. 2A-D for MnO nanocrystal formation.
- TEM transmission electron microscopy
- XRD X-ray powder diffraction
- the nanoparticles produced by the methods of the invention can be deposited onto a solid surface following precipitation and dispersion.
- the deposited nanoparticle dispersion is dried; drying is conveniently performed at room temperature.
- monodisperse particle thin films are provided, such as can be used for the many aspects as described herein, e.g., ultra-high density recording media.
- Suitable solid surfaces or flat substrates include, without limitation, SiO 2 , Si, glass or carbon, for the preparation of thin films. This is especially useful for magnetic metal particles, which are surrounded by protective ligands, and which produce magnetic particle thin films.
- Annealing of the particle dispersion to the thin film can comprise temperatures of from about 500° C. to about 600° C. and produces mirror-like thin films; such films can have controlled coercivities, e.g., of from about 500 Oe to about 6500 Oe.
- manganese oxide MnO
- monodisperse and uniform nanocrystals of 7 nm in length were synthesized by thermal decomposition of manganese acetate in the presence of oleic acid at high temperature. (See Example 1).
- the method of this embodiment involves mixing manganese acetate precursor, e.g., at room temperature (e.g., 25-60° C.), with an organic solvent including at least one organic stabilizing ligand as described herein, e.g., a sulfonic acid, a sulfuric acid, a phosphonic acid, a phosphoric acid, a carboxylic acid, or a thiol, to form a reaction mixture in a non-aqueous environment.
- Suitable organic stabilizing ligands are carboxylic acids, such as oleic acid.
- Exemplary organic solvents include, without limitation, trialkylamines, such as trioctylamine or trimethylamine-N-oxide.
- the mixture is then heated to a temperature of from about 300° C. to about 350° C., and maintained at the elevated temperature for a time sufficient to allow the formation of monodisperse manganese oxide nanoparticles in organic solution and decomposition of the manganese acetate.
- the time sufficient is from about 45 minutes to about 1 hour. In another embodiment, the time sufficient is about 1 hour.
- the mixture is heated at about 320° C. In an exemplary aspect, after about 1 hour at the high temperature, the organic solution is cooled to a temperature lower than the reaction temperature, i.e., to about 100° C., which results in a gradual increase in crystal size.
- the manganese oxide nanoparticles are then extracted into a hydrocarbon solvent, e.g., an alkane such as hexane, by precipitation in alcohol, e.g., ethanol, followed by centrifugation and redispersion.
- a hydrocarbon solvent e.g., an alkane such as hexane
- alcohol e.g., ethanol
- the resulting extracted monodisperse manganese oxide (MnO) nanoparticles have a uniform size, e.g., from about 6 nm to about 20 nm, or from about 12 nm to about 20 nm, or from about 6 nm to about 7 nm, and are monodisperse and stable to oxidation over time.
- the resulting manganese oxide nanoparticles are ligand-capped due to the organic solvent components, thus resulting in an organic outside coating.
- the manganese acetate precursor is anhydrous.
- the above-described monodisperse MnO nanoparticles are further oxidized to obtain Mn 3 O 4 nanoparticles.
- the oxidation comprises exposing the manganese oxide particles to air or chemical oxidation to obtain further oxidized Mn 3 O 4 nanoparticles.
- the manganese oxide particles can be exposed to trimethylamine-N-oxide to obtain ligand-capped Mn 3 O 4 nanoparticles. (See, e.g., Example 1).
- the resulting Mn 3 O 4 nanoparticles are also monodisperse and uniform in size and can comprise a nanocrystal size of from about 3 nm to about 20 nm, e.g., about 7 nm.
- Mn 3 O 4 has applications in its pure form as one of the raw materials in the manufacture of professional grade ferrites, which find use in electronic industries. Manganese oxides are also appealing for use in lithium-ion cells, as manganese is inexpensive and environmentally benign. Other uses for Mn 3 O 4 produced in accordance with the methods of this invention include electrode materials for rechargeable lithium batteries; corrosion inhibiting pigments for epoxy-polyamide and epoxy-ester-based primers and top coatings; starting material for the manufacture of soft magnetic materials such as manganese zinc ferrite, which is useful for magnetic cores in transformers for power supplies; and in the manufacture of welding rods and fluxes.
- Exchange spring magnets which are composed of a two phased distribution of hard- and soft-magnetic grains, have potential application as permanent magnets.
- An Fe 3 O 4 /Mn 3 O 4 superlattice is a strong candidate for such types of magnets.
- the hard-magnetic grains provide the high anisotropy and coercive fields, while the soft magnetic grains enhance the magnetic moments.
- the soft grains are pinned to the hard-magnet grains at the interfaces by the exchange interaction, while the center of the soft-magnet grains can rotate in a reversed magnetic field.
- Such magnets are characterized by enhanced remnant magnetization and reversible demagnetization curves, since the soft grains will rotate back into alignment with the hard grains when the applied field is removed.
- a superlattice which consists of a series of repeatedly stacked layers with a substantially enhanced interface effect, is an ideal system for the interface studies.
- the preparation of a Fe 3 O 4 /Mn 3 O 4 superlattice, or a superlattice thin film is encompassed, because the Fe 3 O 4 and Mn 3 O 4 components have very different magnetic anisotropies and coupling strengths.
- the Mn 3 O 4 component may significantly improve the performance of ferromagnetism due to its spring exchange or couple exchange.
- Mn 3 O 4 nanoparticles formed according to the methods described herein can be used in magnetoresistive materials, e.g., colossal magnetoresistive materials.
- magnetoresistive oxide thin films comprising, for example, Mn 3 O 4 can be made using electrical field deposition technology.
- the present invention encompasses a method for forming monodisperse, uniformly sized, and stable nanoparticles of iron oxide (FeO).
- the method involves mixing iron acetate precursor, e.g., Fe(II)acetate, with an organic solvent, e.g., at room temperature (e.g., 25-60° C.), to form a reaction mixture, which is non-aqueous.
- the organic solvent includes at least one organic stabilizing ligand, e.g., sulfonic acid, sulfuric acid, phosphonic acid, phosphoric acid, carboxylic acid, or thiol.
- Suitable organic stabilizing ligands include carboxylic acids, such as oleic acid.
- Organic solvents including trialkylamines, e.g., trioctylamine or trimethylamine-N-oxide, are suitable for use in the present methods.
- the mixture is then heated to a temperature of from about 200° C. to about 260° C., preferably, about 250° C., and maintained at the elevated temperature for a timer period of from about 45 minutes to about 1 hour, i.e., a time sufficient to allow the formation of monodisperse iron oxide nanoparticles in organic solution and decomposition of the iron acetate.
- the iron oxide nanoparticles are then extracted into a hydrocarbon solvent, e.g., an alkane such as hexane, by precipitation in non-polar solvent, such a alcohol, e.g., ethanol, centrifugation and redispersion.
- a hydrocarbon solvent e.g., an alkane such as hexane
- non-polar solvent such as a alcohol, e.g., ethanol
- the resulting extracted monodisperse iron oxide (MnO) nanoparticles have a uniform size, e.g., about 3 to about 20 nm, or from about 12 to about 20 nm, or 7 nm, and are stable to oxidation over time.
- the resulting iron oxide nanoparticles are further ligand-capped, thus resulting in an organic outside coating, which provides the aforementioned advantages for a use in pharmaceutical, medically-related, or cosmetic compositions, as well as one or more of the above-described industrial applications, as but a few illustrative examples.
- the iron acetate precursor is anhydrous.
- the present invention embraces a method for forming monodisperse, uniform and stable nanoparticles of zinc oxide (ZnO).
- the method of this embodiment involves mixing zinc acetate precursor, e.g., at room temperature (e.g., 25-60° C.), with an organic solvent, e.g., a trialkylamine, including at least one organic stabilizing ligand, e.g., a sulfonic acid, a sulfuric acid, a phosphonic acid, a phosphoric acid, a carboxylic acid, or a thiol, to form a reaction mixture in a non-aqueous organic solution.
- an organic solvent e.g., a trialkylamine
- organic stabilizing ligand e.g., a sulfonic acid, a sulfuric acid, a phosphonic acid, a phosphoric acid, a carboxylic acid, or a thiol
- Suitable organic stabilizing ligands include carboxylic acids, such as, for example, oleic acid.
- Other suitable organic solvents include trialkylamines, such as trioctylamine or trimethylamine-N-oxide.
- the mixture is then heated to a temperature of from about 320° C. to about 400° C., preferably, about 360° C., and maintained at the elevated temperature for a time period of from about 45 minutes to about an hour, i.e., a time sufficient to allow the formation of monodisperse zinc oxide nanoparticles in organic solution and decomposition of the zinc acetate.
- the zinc oxide nanoparticles are then extracted into a hydrocarbon solvent, e.g., an alkane such as hexane, at a temperature lower than that of the heating temperature, e.g., 100° C., by precipitation in a polar organic solvent such as an alcohol, e.g., ethanol, or flocculating agent (or flocculent), followed by centrifugation and redispersion.
- a hydrocarbon solvent e.g., an alkane such as hexane
- a polar organic solvent such as an alcohol, e.g., ethanol, or flocculating agent (or flocculent)
- the resulting extracted monodisperse zinc oxide (ZnO) nanoparticles have a uniform size, and are stable to oxidation over time.
- the resulting zinc oxide nanoparticles are further ligand-capped due to the organic solvent components, thus resulting in an organic outside coating.
- the zinc acetate precursor is anhydrous.
- the above method is employed for the formation of zinc oxide nanorods, which are uniform in size, e.g., 2-3 nm ⁇ 30-40 nm, and can be used in a variety of applications as described below.
- both spherical nanoparticles and nanorods i.e., rods with diameters of 2-10 nm and aspect ratios in the range of 1:5 and up to 1:40
- this is due to the asymmetric crystal structure of zinc oxide.
- the zinc acetate:surfactant ratio is 1:3 or greater; for the generation of nanorod nanoparticles, the zinc acetate:surfactant ratio is less than 1:2.
- the preparation of rods or spheres of zinc oxide depends on the reaction conditions, including choice of ligand and/or organic solvents, such as trioctylamine for rods and 1-hexadecanol or 1-octadecene for spheres.
- ZnO nanoparticles prepared according to the methods of the present invention include serving as a material for the emission of ultra-violet light, i.e., as a substitute for GaN, a well-known UV laser material.
- ZnO may also be used for optoelectronic applications in the short wavelength range (green, blue, UV).
- the high exciton binding energy in ZnO (about 60 meV vs. 25 meV for GaN) would allow for excitonic transitions even at room temperature, which could mean a higher radiative recombination efficiency for spontaneous emission, as well as a lower threshold voltage for laser emission.
- ZnO has several fundamental advantages over the use of GaN: (1) the free exciton of ZnO is bound with 60 meV, much higher than that of GaN (21-25 meV); (2) ZnO has a native substrate; (3) wet chemical processing of ZnO is possible; and (4) ZnO is more resistant to radiation damage, for example, compared with Si or GaAs, which are poor performers for radiation damage. ZnO epitaxy layers can also serve as very suitable materials for photonic devices in the ultraviolet region.
- the use of semiconductor quantum well structure as a low-threshold optical gain medium represents a sizable advancement in semiconductor laser technology.
- ZnO nanoparticles produced according to the present methods can address this need.
- electrical field deposition technology can be used to produce thin films comprising ZnO nanoparticles, including ZnO nanorods, according to the present invention.
- the present invention encompasses compositions comprising the above-described metal oxide nanocrystals for use in cosmetic formulations and compositions.
- cosmetic formulations and compositions include, without limitation, makeups, skin and body care products, such as topically-applied skin and body care products, powders, lotions, creams, ointments, conditioners, shampoos, fragrances, sunblocks, sunscreens, suntanning lotions, deodorants, deodorizers, and hair colors and dyes.
- Topically-applied products and product formulations are advantageous.
- Nonlimiting examples of skin care formulations that may contain the nanoparticles of the invention are found, for example, in U.S. Pat. No. 6,168,798 to O'Halloran, and U.S. Pat. No. 5,885,596 to P. Parab.
- the present invention encompasses pharmaceutical and medical formulations and compositions comprising the above-described metal oxide nanocrystals.
- the outer organic coating which is comprised of organic molecules that act as capping agents for the surface of the nanoparticles of the invention, endow the nanoparticles with the beneficial and clinically relevant property of crossing the blood/brain barrier.
- Such pharmaceutical and medical formulations and compositions typically include a physiologically or pharmaceutically acceptable carrier, diluent, excipient, or vehicle, typically comprising a suitable liquid or solution such as sterile physiological saline or other physiologically acceptable injectable aqueous liquids.
- compositions comprising the nanoparticles can be prepared in sterile solution or suspension, or resuspended in pharmaceutically- and physiologically-acceptable aqueous or oleaginous vehicles, which may contain preservatives, stabilizers, and material for rendering the solution or suspension isotonic with body fluids (i.e. blood) of the recipient.
- excipients, diluents, vehicles, or carriers suitable for use include water, phosphate buffered saline (pH 7.4), 0.15M aqueous sodium chloride solution, dextrose, glycerol, dilute ethanol, and the like, and mixtures thereof.
- Illustrative stabilizers are polyethylene glycol, proteins, saccharides, amino acids, inorganic acids, and organic acids, which may be used either on their own or as admixtures.
- the amounts or quantities, as well as the routes of administration used, are determined on an individual basis, and correspond to the amounts used in similar types of applications or indications known to those of skill in the art.
- MnO nanoparticles An example of the synthesis procedure to produce metal oxide nanocrystals according to the present invention is provided.
- this Example the formation of MnO nanoparticles is described.
- 4 mmol of dry manganese acetate (Mn(CO 2 CH 3 ) 2 , Aldrich) was added to a mixture containing 15 ml of trioctylamine and 3 g of oleic acid (12 mmol) at room temperature.
- the resulting mixture was heated rapidly to 320° C. over 10 to 15 minutes; during this time, the solution gradually changed to black.
- the solution was maintained at 320° C. for 1 hour under N 2 flow to yield uniform MnO nanocrystals with yields of up to 80%.
- the nanocrystals were cooled to room temperature, 25-60° C., and extracted into hexane by precipitation with ethanol in an amount between 5-200% volume of the original volume in the reaction vessel.
- the extraction temperature was, in general, a temperature cooler than the reaction/heating temperature. In some instances, a temperature of less than 200° C. was used, for example, 100° C.
- the extracted, precipitated material was centrifuged for 5-100 minutes at about 3000-6000 rpm and redispersed into hexane solvent.
- TEM samples were prepared by placing a drop of a dilute hexane dispersion of nanocrystals on the surface of a 400 mesh copper grid backer with Formvar and were dried in a vacuum chamber at 80° C. for 1 hour.
- XRD samples were prepared by drying a dispersion of nanocrystals on a piece of Si (100) wafer. The XRD spectrum ( FIG.
- Controlling evaporation conditions e.g., by using a closed system at room temperature and allowing for diffusion to remove the solvent over periods of from 1-10 hours, allowed for the formation of a three-dimensional close-packed superlattice assembly of 14 nm MnO nanocrystals ( FIG. 2B ).
- SAED Selected area electron diffraction patterns
- Monodisperse MnO nanoparticles of from about 12-20 nm in size were prepared as described above, and an annealing step was further performed after the temperature was kept at 320° C. for 1 hour by carefully cooling the resulting solution to 100° C. ( FIGS. 2A-2D ).
- c r c ⁇ ⁇ exp ⁇ ( 2 ⁇ ⁇ V m ⁇ 1 ) ( RT ⁇ ⁇ r ) ( 1 )
- FIG. 6B shows the cube of the particle radius plotted versus time. It can be inferred from the roughly linear dependence that the increase in particle size is dominated by diffusion-limited growth at this temperature.
- stoichiometric ratios were in the range of 2-6 times the molar ratio of oxidant:metal precursor, e.g., 1 Mn(CH 3 CO 2 ) 2 :4[CH 3 ] 3 NO.
- highly uniform preparations of ligand-capped nanocrystals of FeO (Wurstite structure, Fm3m) of 14 nm in size were formed using the method as described for MnO, by substituting Fe(II) acetate as the precursor.
- This Example describes the formation of FeO nanoparticles prepared using the new synthesis according to the present invention.
- This method affords better control of the oxidation states of iron.
- dehydrated iron acetate i.e., Fe 2+ salt
- monodispersed, metastable wustite phase FeO nanocrystals were synthesized.
- dry iron acetate was mixed with trioctylamine organic solvent (10-20 mL) containing oleic acid as surfactant/stabilizing ligand (2-5 mL), and the mixture was heated over 10 to 15 minutes to a temperature of 250° C. The reaction was kept at this temperature for 1 hour under N 2 .
- the FeO nanoparticles were cooled to 100° C., and were extracted into hexane by precipitation with ethanol, followed by centrifugation and redispersion in hexane as described hereinabove.
- the resulting nanocrystals were characterized using TEM (JEOL, 100cx, acc. 100 kV) and X-ray powder diffraction (XRD, Scintag X 2 ), as described in Example 1.
- Further oxidized forms of iron oxide, e.g., Fe 2 O 3 and Fe 3 O 4 , nanoparticles were prepared using oxidizing agents in the synthetic process.
- Trimethylamine N-oxide is one example of an oxidizing agent that can be used in this example.
- oxidants include pyridine N-oxide (C 5 H 5 NO), phenyl sulfoxide (C 12 H 10 SO) and dimethyl sulfoxide ([CH 3 ] 2 SO).
- pyridine N-oxide C 5 H 5 NO
- phenyl sulfoxide C 12 H 10 SO
- dimethyl sulfoxide [CH 3 ] 2 SO.
- This Example describes the formation of Cu 2 O nanoparticles prepared using the synthesis methods according to the present invention. This method affords better control of the formation of Cu 2 O and further oxidation to CuO nanoparticles.
- rated copper acetate was used as the copper precursor and monodispersed, metastable cuprite phase Cu 2 O nanocrystals (2 nm to 50 nm) were synthesized.
- the copper acetate starting material was mixed with a trioctylamine organic solvent containing oleic acid and was heated to 280° C. over a 10 to 15 minute time period. The reaction was maintained at the high temperature for about 1 hour under N 2 .
- the reaction vessel was cooled to room temperature, and copper oxide nanocrystals were extracted into hexane by precipitation with ethanol, followed by centrifugation and redispersion in hexane as described above.
- the resulting Cu 2 O nanoparticles were analyzed by XRD and TEM as shown in FIGS. 9A-9G .
- Further oxidized CuO nanoparticles could also be prepared by further oxidation of Cu 2 O nanoparticles by using the oxidants described in Example 2.
- Such copper oxide nanoparticles are suitable for use as material comprising solar batteries, for example.
- Copper Oxide Nanocrystals are a benchmark model for nanotechnology, given that the tunability of optical properties, and the stabilization of specific phases are uniquely possible at the nanoscale.
- copper (I) oxide (Cu 2 O) is a metal-oxide semiconductor with promising applications in solar energy conversion and catalysis.
- the invention provides a method for preparing highly uniform monodisperse nanocrystals of Cu 2 O. The synthetic procedure serves to demonstrate our development of a generalized method for the synthesis of transition metal oxide nanocrystals, which involves thermal decomposition of metal acetate-surfactant complexes in hot organic solvents.
- Copper (I) oxide (Cu 2 O) is a p-type metal-oxide semiconductor with promising applications in solar energy conversion and catalysis. (1-4, wherein the numbers in parenthesis for Example 3 refer to references as set forth below herein).
- Cu 2 O also called cuprous oxide
- the large excitonic binding energy (140 meV) allows the observation of a well-defined series of excitonic features in the absorption and luminescence spectrum at low temperature, (5,6) yet studying quantum confinement effects or modifying the behavior of the direct forbidden band gap is challenging. (7,8) It is also a useful compound to study the influence of electron-correlation effects on the electronic structure of transition metal compounds in general, and the high T c superconductors in particular.
- Crystals of a finite size assume a modified morphology and/or crystal structure in order that the atoms, especially those at the surface, can adopt the most stable equilibrium configuration of minimal energy. (2) Consequently, some materials, which are not stable in bulk and do not exist in ambient atmosphere, may become substantially more stable at the nanoscale. This is due to the large contribution of surface energy which can stabilize the origin of unique phases. (19-21) Bulk Cu 2 O, with a cuprite structure, absorbs oxygen from the air and can readily convert to CuO at room temperature. (2)
- the synthetic procedure used for the Cu/Cu 2 O/CuO system serves to illustrate our development of a generalized method for the synthesis of transition metal oxide nanocrystals, which involves metal acetates as the precursors and thermal decomposition of metal acetate-surfactant complex in a hot organic solvent.
- this method is termed “TDMA” (thermal decomposition of metal acetates).
- the method is effective for the synthesis of 1st row transition metal and transition metal oxide nanocrystals ( FIG. 11 ).
- the method of the invention insures the preparation of highly uniform, monodisperse nanocrystals of Cu 2 O in high yield (typically >50-60% wrt conversion of precursor).
- the process of full oxidation from Cu to Cu 2 O nanocrystals can take up to a few hours depending on the conditions and particle size but in all cases transformation to Cu 2 O is complete, in contrast to previous reports.
- the crystal structure of Cu 2 O is cuprite, which is composed of 8 cubes, as shown in s- FIG. 16 . In each cube, Cu atoms occupy all the fcc positions and two oxygen atoms occupy two diagonal tetrahedral interstices.
- the oxidation can be qualitatively interpreted as an oxygen diffusion and lattice expansion process.
- Cu nanocrystals When Cu nanocrystals are exposed to air, electrons are transferred from Cu atoms to oxygen and the oxygen anions produced diffuse in the tetrahedral interstices.
- the crystal structure and material changes from fcc Cu to cuprite Cu 2 O with a corresponding lattice expansion (see FIGS. 12-15 ).
- Cu and Cu 2 O share the high-symmetry cubic structure, while CuO is a low-symmetry monoclinic structure.
- the oxidation transition to Cu 2 O is accomplished by oxygen atoms' diffusion into tetrahedral interstices and lattice expansion.
- FIGS. 12A , and 13 A Nanocrystal assembly from hexane solutions into closed packed arrays was also observed in FIGS. 12A , and 13 A, demonstrating the uniformity of the particle size and retention of the oleic acid capping group.
- FIG. 12B shows a view of a close-packed superlattice of 6 nm Cu 2 O nanocrystals. The nanocrystals are clearly suitable candidates for the preparation of binary superlattice structures. (26) If the particle is oriented along a low-index zone axis, the distribution of atoms on can be imaged.
- FIG. 12C gives a profile HRTEM image of cubic Cu 2 O nanocrystals. The lattice plane distance is 1.88 ⁇ , indicating (2 1 0) planes. Selected area electron diffraction patterns ( FIG. 12D ) can be indexed to cubic symmetry, indicating cubic crystal structure of Cu 2 O.
- the role of the capping ligand is very important to nanocrystal synthesis, during nucleation, growth and stabilization of the particles post-synthesis with respect to agglomeration and stabilization in organic solvents.
- a decrease of particle size from 10.7 ⁇ 0.7 nm to 3.6 ⁇ 0.8 nm was observed as the molar ratio of copper (I) acetate to oleic acid was increased from 0.08 to 0.6 (supporting information, FIG. 15 ).
- the ability of controlling particle size is of interest to prepare high quality, monodisperse cuprous oxide nanocrystals and to characterize their optical properties.
- Monodisperse, stable Cu 2 O nanocrystals were synthesized by using a novel, yet simple wet chemistry route. This method gives a high yield of nanocrystals and narrow size distribution.
- the Cu 2 O nanocrystal size could be controlled from 3.6 nm to 10.7 nm by controlling the molar ratio of oleic acid to copper precursor. From structural analysis, it was concluded that the Cu 2 O phase is highly stabilized in these nanocrystals.
- the investigated Cu 2 O nanocrystals show a band gap transition. In addition, they display a band gap transition of the surface CuO layer.
- XPS reveals an amorphous layer of CuO on the Cu 2 O nanocrystal surface and the reduction of surface CuO to Cu 2 O by X-ray irradiation.
- a solution containing 4 mmol copper acetate, 4 ml oleic acid and 15 ml trioctylamine was quickly heated to 180° C. under Nitrogen, the color gradually changed from forest green to coffee, finally producing a gray colloid. The presence of oxygen or water is highly undesirable during the decomposition and nucleation stage. The solution was kept at this temperature for 1 hour.
- the gray colloid gradually changed to a deep burgundy solution.
- the solution was kept at 270° C. for an hour before it was cooled down to RT (room temperature), and particles were precipitated by ethanol and redispersed in hexane.
- the particles (Cu) are observed to be initially dark red, forming a purple/dark-red solution when dispersed in hexane.
- the resulting red purple copper particles gradually oxidize to Cu 2 O in hexane, and produce a deep green solution.
- the final Cu 2 O nanocrystals were very stable in hexane, both with respect to oxidation and agglomeration, and ready to be used for further experiments.
- TEM and XRD characterization—Cu 2 O nanocrystals were characterized using transmission electron microscopy (JEOL CX100) with an accelerating voltage of 100 kV, high resolution TEM (JEOL 3000F) with an accelerating voltage of 300 kV, and X-ray powder diffraction (Scintag X 2 X-ray diffractometer).
- TEM samples were prepared by placing a drop of a dilute hexane dispersion of nanocrystals on the surface of a 400 mesh copper grid backed with Formvar, and were dried in a vacuum chamber for 1 hr.
- JEOL 3000F was used for lattice imaging.
- XRD samples were prepared by drying a dispersion of nanocrystals on a piece of Si (100) wafer.
- UV-Vis characterization The UV-vis absorbance and fluorescence spectra were measured on a Varian Cary 50 and a Varian Eclipse fluorescence spectrophotometer, respectively.
- XPS characterization The XPS experiment was performed on PHI 5500 model spectrometer equipped with an Al KR monochromator X-ray source running at 15 kV and 23.3 mA, a hemispherical electron energy analyzer, and a multichannel detector. The test chamber pressure was maintained below 2 ⁇ 10 ⁇ 9 Torr during spectral acquisition. A low-energy electron flood gun was used to neutralize the possible surface charge.
- the XPS binding energy (BE) was internally referenced to the aliphatic C(1s) peak (BE, 284.6 eV).
- Survey spectra were acquired at an analyzer pass energy of 93.9 eV and BE resolution of 0.8 eV, while high resolution spectra were acquired with a pass energy of 23.5 eV and BE resolution of 0.05 eV.
- the takeoff angle is defined as the angle between the surface normal and detector.
- High-resolution spectra were resolved by fitting each peak with Guassian-Lorentz functions after subtracting the background using the PHI data processing software package under the constraint of setting a reasonable BE shift and characteristic full width at half-maximum range.
- Atomic concentrations were calculated by normalizing peak areas to the elemental sensitivity factor data provided by the PHI database.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Nanotechnology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Composite Materials (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- General Physics & Mathematics (AREA)
- Materials Engineering (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
- Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
- Oxygen, Ozone, And Oxides In General (AREA)
- Inorganic Compounds Of Heavy Metals (AREA)
Abstract
The present invention describes methods for preparing high quality nanoparticles, i.e., metal oxide based nanoparticles of uniform size and monodispersity. The nanoparticles advantageously comprise organic alkyl chain capping groups and are stable in air and in nonpolar solvents. The methods of the invention provide a simple and reproducible procedure for forming transition metal oxide nanocrystals, with yields over 80%. The highly crystalline and monodisperse nanocrystals are obtained directly without further size selection; particle size can be easily and fractionally increased by the methods. The resulting nanoparticles can exhibit magnetic and/or optical properties. These properties result from the methods used to prepare them. Also advantageously, the nanoparticles of this invention are well suited for use in a variety of industrial applications, including cosmetic and pharmaceutical formulations and compositions.
Description
- This application is a continuation-in-part of International Application No. PCT/US2004/041141, filed Dec. 9, 2004, which claims the benefit of U.S. Provisional Patent Application No. 60/528,667, filed Dec. 11, 2003, each of which is incorporated herein by reference in its entirety.
- The United States Government may have certain rights in the present invention pursuant to partial funding by grants from the Materials Research Science and Engineering Center (DMR-0213574 MRSEC) and the Nanoscale Science and Engineering Center (CHE-0117752 NSEC) of the National Science Foundation and pursuant to partial funding by the U.S. Department of Energy, Office of Basic Energy Sciences, through the Catalysis Futures grant DE-FG02-03ER15463, and in part by the (i) the MRSEC program of the National Science Foundation under award number DMR-0213574, and NSF-CAREER award, DMR-0348938.
- This patent disclosure contains material which is subject to copyright protection. The copyright owner has no objection to the facsimile reproduction by anyone of the patent document or the patent disclosure, as it appears in the U.S. Patent and Trademark Office patent file or records, but otherwise reserves any and all copyright rights.
- The present invention relates generally to nanoparticles of transition metals, e.g., nanocrystals, their synthesis and characterization. More particularly, the invention relates to the synthesis of metal oxide nanoparticles that are monodisperse, uniform in size and stable. The nanoparticles of the present invention are safer and more environmentally benign than those prepared by previously described methods.
- Nanocrystals typically have a diameter of between 1 and 100 nm and may contain as few as a hundred or as many as tens of thousands of atoms having size-dependent properties and the possibility of arrangement in micro (and nano) assemblies. Nanocrystals have become the focus of intensive research due to their numerous applications in diverse fields such as catalyst production, ultramodern electronic and electrooptical devices, supermagnets, photographic suspensions, etc.
- The development, characterization and exploitation of nanometer sized materials is an exceptionally active and rapidly expanding field. The exploration of complex structures on the nanometer size scale is underway in a variety of disciplines, such as chemistry, physics and engineering. The importance of such new interdisciplinary studies may be realized in the design and characterization of advanced materials. Studies of nanometer sized semiconductors, metals and refractories (nanoceramics) provide powerful examples of how control of particle size can optimize material performance.
- The ability to engineer materials and assemble devices on the nanometer size scale is a goal in fields as diverse as opto-electronics, catalysis, ceramics and magnetic storage. To produce functional materials and devices, nanocrystals must be organized into solid superstructures while maintaining and enhancing their novel mesoscopic properties. In addition to this general requirement, there are formidable practical constraints. For example, materials must display mesoscopic phenomena at or near room temperature and be robust both chemically and mechanically. In addition, materials must be produced by cost effective methods. These challenges must be met to transform scientific curiosities into technological advances.
- The applications of nano-sized particles in many aspects of industry and commercial products require efficient and economical ways to synthesize such particles that are of high quality and exhibit desired properties, e.g., magnetism and stability over time. Conventional techniques for nanoparticle production have typically been beset by drawbacks in the formation of uniformly-sized and chemically stable nanoparticle products, thus jeopardizing the reliability of the systems in which they are employed. Needed in the art are new methods that overcome existing problems for readily forming high quality and stable nanoparticles of several different metal oxides that exhibit desired properties for widespread use. Also needed are new and reliable types of metal oxide nanoparticle products with improved characteristics and properties for use in diverse applications. This present invention addresses and responds to these needs.
- It is an aspect of the present invention to provide new methods of producing nanoparticles, such as metal oxide-based nanoparticles (also referred to as nanocrystals herein). The methods are economical and efficient, particularly due to the ready availability of starting material or metal precursors used in the methods. Through the practice of the methods, high-quality nanoparticles are formed having the characteristics of uniform size, monodispersity, stability (i.e., lack of degradation due, for example, to oxidation) as well as stability in non-polar solvents due to the presence of one or more non-polar capping groups at the surface, and magnetic properties. The methods are suitable for obtaining metal-based nanoparticles, particularly transition metal oxides, including for example and without limitation, zinc (Zn), iron (Fe), manganese (Mn), cobalt (Co), ruthenium (Ru), copper (Cu), scandium (Sc), titanium (Ti), vanadium (V), chromium (Cr), molybdenum (Mo), yttrium (Y), zirconium (Zr), hafnium (Hf), and nickel (Ni) metal-based nanoparticles.
- It is another aspect of the present invention to provide new methods for the synthesis of nanocrystals to attain well-defined particle size and morphology. In accordance with this invention, a non-hydrolytic synthetic method is provided for effectively tailoring a uniform particle size and controlling the homogeneous dispersion of ultrafine metal oxide nanocrystals, e.g., iron oxide nanocrystals, zinc oxide nanocrystals and manganese oxide nanocrystals. Magnetic nanocrystals, and uses thereof, of metal oxides, e.g., manganese oxide, provide a particular aspect of this invention. In accordance with the invention, the method involves a non-aqueous environment, e.g., hydrocarbon-based solvents, in which anhydrous acetate precursors of a given metal are used. The use of a metal acetate starting material or precursor in such a solvent environment is a unique aspect of the present invention. The method further involves heating the metal acetate precursors, which are readily available and inexpensive, to a high temperature, e.g., greater than about 100° C. The metal acetate is then decomposed at high temperature in the presence of an organic solvent, e.g., trialkylamine, comprising at least one organic stabilizing ligand (also referred to as an organic stabilizer or organic ligand), e.g., oleic acid. The metal oxide nanoparticles are extracted at a temperature lower than that of the reaction temperature, e.g., room temperature, using a flocculating agent, e.g., a polar organic solvent, to precipitate the metal oxide nanoparticles into hydrocarbon solvent, such as an alkane. The metal oxide nanocrystals resulting from the methods of the invention are monodisperse, of uniform size, and are enclosed (packaged) in an organic outside layer or coating (e.g., ligand capped). Particular monodisperse metal oxide nanoparticles produced by the present methods include, without limitation, zinc oxide nanoparticles, manganese oxide nanoparticles, iron oxide nanoparticles and cupric oxide nanoparticles.
- In a related aspect, the present invention provides a method of producing uniformed sized nanoparticles having useful properties, such as light reflecting and absorbing properties for use in preventative or therapeutic products and formulations to prevent, reduce, retard, ameliorate, or eliminate photodamage and/or photoaging in a human or animal due to exposure to sunlight. Such products and formulations are useful as sunscreens, suntan lotions and sunblocks. and as components thereof. The nanoparticles also may have magnetic properties, which are significantly different from the bulk material and which enhance their use in magnetic recording media, and read and write heads, as well as in a number of imaging, optical and electrical methods and devices. As but one example, the nanoparticles find use in the area of electrical field deposition technology for thin films, and in laser technology for use in laser materials. In addition, the nanoparticles have a significant grain size. Control of grain size is important in being able to tune the properties of a specific material for a particular application. For example semiconducting materials such as cadmium selenide, have a tunable bandgap energy as a function of size in the nanoscale regime which gives rise to tunable optical properties. Their outer organic layer or coating, uniform size and composition should allow the nanoparticles to cross the blood brain barrier, thus affording materials for formulating into useful compositions, e.g., drugs, small molecules, for medical and pharmaceutical uses. The properties of the nanoparticles prepared by the methods of this invention provide further commercially applicable utility for these materials in a variety of products such as many types of cosmetics, polymers, plastics, paints, and a variety of other industrial products and formulations. Other examples of applications of the nanoparticles prepared by the methods of this invention include skin products, drug delivery vehicles, and MRI contrast enhancement agents.
- In another aspect, the present invention provides compositions comprising the monodisperse and stable nanoparticles for use in cosmetics and pharmaceutical compositions. For pharmaceutical compositions, a pharmaceutically or physiologically acceptable carrier, diluent, excipient, or vehicle is further included.
- Yet another aspect of the present invention provides efficient and inexpensive methods for synthesizing nanoparticles, in particular, specific transition metal oxide nanoparticles, such as iron oxide, manganese oxide, and zinc oxide, in which the method comprises treating a metal acetate precursor under anhydrous conditions in the presence of organic solvent, e.g., trialkylamine, and at least one organic stabilizing ligand, e.g., oleic acid, and at temperature of from about 100° C.-150° C., and decomposing the metal acetate to produce metal oxide nanoparticles of uniform crystal size.
- A further aspect of the present invention provides high quality monodisperse, uniformly-sized nanoparticles, which are stable; resist degradation, e.g., via oxidation or nonpolar solvents; are encased or packaged in an outer organic layer or coating; and which result from the practice of the described methods. The nanoparticles can be magnetic and can comprise thin films. A composition comprising the nanoparticles of the invention can be used for the preparation of magnetic recording media, read and write heads, imaging devices or components thereof (including contrast enhancement agents in MRI imaging and/or other biomedical imaging applications), electrical field deposition devices or components thereof, magnetic devices or components thereof, optical devices or components thereof, or thin films. Such nanoparticles can be employed in a variety of applications, including those described hereinabove.
- In a particular aspect, the present invention involves a method of synthesizing iron oxide (FeO) nanoparticles of uniform size and monodispersity comprising subjecting iron acetate starting material to a temperature of from about 200° C. to about 260° C., preferably about 250° C., in an organic solvent, e.g., trialkylamine, in the presence of oleic acid to produce iron oxide nanocrystals having the desired properties following decomposition of the iron acetate and precipitation of the FeO nanocrystals with a flocculent, e.g., a polar organic solvent, into hydrocarbon solvent under conditions of a temperature lower than the reaction temperature used with the iron acetate, e.g., room temperature, or 100° C. or lower.
- In another particular aspect, the present invention involves a method of synthesizing monodispersed and uniform manganese oxide, i.e., MnO and Mn3O4, nanoparticles comprising subjecting manganese acetate starting material to a temperature of from about 300° C. to about 350° C., preferably about 320° C., in an organic solvent, e.g., trialkylamine, in the presence of oleic acid to produce manganese oxide nanocrystals having the desired properties following decomposition of the manganese acetate and precipitation of the MnO nanocrystals with a flocculent, e.g., a polar organic solvent, into hydrocarbon solvent under conditions of a temperature lower than the reaction temperature used with the iron acetate, e.g., room temperature, or 100° C. or lower. The method produces superlattices of MnO (
FIG. 2F ). Mn3O4 nanocrystals can be prepared by oxidation of the MnO nanoparticles, e.g., by natural oxidation of MnO in air; such Mn3O4 nanocrystals have magnetic properties, e.g., ferromagnetic properties. - In a related particular aspect, the Mn3O4 nanocrystals synthesized in accordance with this invention provide a magnetic material having magnetic properties and applications. A Mn3O4/Fe3O4 superlattice comprising the Mn3O4 nanocrystals provides a magnet. A superlattice thin film comprising Mn3O4/Fe3O4 is further provided by the invention. In addition, magnetoresistive material, involving magnetoresistive oxide thin films can be produced using electrical field deposition technology, which is a technique practiced in the art.
- Additional aspects, features and advantages afforded by the present invention will be apparent from the detailed description, figures, and exemplification hereinbelow.
-
FIGS. 1A and 1B show the crystalline characteristics of MnO nanocrystals prepared according to the present invention.FIG. 1A shows X-ray powder diffraction (XRD) patterns of 7 nm diameter MnO nanocrystals exhibiting the highly crystalline peaks that can be matched to the series of Bragg reflections corresponding to the standard and phase pure cubic rock salt structure of MnO.FIG. 1B shows the indexed selected area electron diffraction patterns (SAED) of the MnO nanocrystals formed by the methods of the invention and having the XRD patterns shown inFIG. 1A . -
FIGS. 2A-2F show transmission electron micrographs (TEM) of monodispersed nanoparticles of MnO prepared as described according to the present methods.FIG. 2A shows a TEM of MnO nanoparticles of 6-7 nm. (50 nm scale).FIG. 2B shows a TEM of MnO nanoparticles of 14 nm. (70 nm scale).FIG. 2C shows a TEM of MnO nanoparticles of 16 nm. (125 nm scale).FIG. 2D shows a TEM of MnO nanoparticles of 20 nm. (150 nm scale).FIG. 2E shows a TEM of 16 nm MnO nanoparticles having cubic structure. (30 nm scale).FIG. 2F shows that quality superlattice structures are formed from the MnO nanoparticles synthesized according to the present methods and viewed by TEM. (100 nm scale). -
FIGS. 3A-3C show properties of Mn3O4 nanocrystals prepared according to the present methods by further oxidation of MnO.FIG. 3A shows a TEM of uniformly sized 6-7 nm Mn3O4 nanocrystals, which were oxidized naturally in air. (100 nm scale).FIG. 3B shows the XRD analysis of the Mn3O4 nanoparticles ofFIG. 3A , prepared by the present methods.FIG. 3C shows the indexed SAED analysis of the Mn3O4 nanoparticles analyzed inFIG. 3B . -
FIGS. 4A-4E depict the results of magnetic studies performed on MnO nanoparticles produced by the methods of the present invention. More specifically these figures depict analyses of the magnetic properties of the 14 nm MnO nanoparticles.FIG. 4A shows the results of a Super-conducting Quantum Interference Device (SQUID) analysis of magnitization versus temperature of the MnO nanoparticles. SQUIDs are used to measure the magnetic properties of materials at low temperature.FIGS. 4B-4E (2K, 5K, 20K and 30K, respectively) show hysteresis studies of the MnO nanoparticles at different temperatures.FIGS. 4F-4L depict analyses of the magnetic properties of Mn3O4 nanoparticles.FIG. 4F shows a SQUID analysis of magnitization susceptibility versus temperature of the Mn3O4 nanoparticles.FIGS. 4G-4L (2K, 5K, 10K, 20K, 40K and 50K, respectively) show hysteresis studies of the 14 nm Mn3O4 nanoparticles at different temperatures. -
FIGS. 5A-5E show characteristics of ZnO nanoparticles synthesized by the methods of the present invention.FIGS. 5A (100 nm scale) and 5B (80 nm scale) show TEM analyses of ZnO nanorods (2-3 nm×30-40 nm) produced by the present methods.FIGS. 5C and 5D show a SAED analysis of the ZnO nanorods (2-3 nm×30-40 nm) produced by the methods.FIG. 5E shows an Ultraviolet-Visible Spectrum (UV-vis) of the ZnO nanorods produced by the present methods. The UV-vis shows the absorption profile in this part of the electromagnetic spectrum, thus elucidating the nanocrystals' interaction with light. -
FIGS. 6A and 6B relate to evaluations of particle size of MnO nanocrystals prepared according to the methods of the present invention.FIG. 6A shows the average diameter of MnO nanocrystals as a function of growth over time at 100° C.FIG. 6B shows the data ofFIG. 6A replotted as the particle diameter cubed versus the growth time, in accordance with the LSW model as described in Example 1. -
FIGS. 7A-7E relate to the characteristics of FeOm (13 nm) nanoparticles produced according to the methods of this invention. More particularly,FIG. 7A shows a TEM of the FeO nanoparticles at 300 nm scale;FIG. 7B shows a TEM of the FeO nanoparticles at 200 nm scale;FIG. 7C shows a TEM of the FeO nanoparticles at 100 nm scale;FIG. 7D shows a TEM of the FeO nanoparticles at 500 nm scale; andFIG. 7E shows an XRD of the 13 nm FeO nanoparticles produced by the present methods. -
FIGS. 8A and 8B further relate to zinc oxide (ZnO) nanoparticles in the form of nanorods produced according to the methods of the present invention.FIG. 8A shows an XRD of the ZnO nanorods; andFIG. 8B shows a TEM of the ZnO nanorods (100 nm scale). -
FIGS. 9A-9G relate to copper oxide (Cu2O) nanoparticles produced according to the methods of the present invention.FIG. 9A shows the results of XRD analyses of 2 nm, 4 nm and 6 nm Cu2O nanoparticles produced by the methods of the present invention.FIGS. 9B-9E show TEM images of monodisperse Cu2O nanoparticles at various magnifications, namely at scales of 75 nm, 150 nm, 50 nm and 20 nm, respectively.FIGS. 9F and 9G show TEM images of a Cu2O nanocrystal superlattice (10 nm scale and 15 nm scale, respectively). -
FIGS. 10A-10B illustrate (FIG. 10A ) X-ray powder diffraction patterns of 5 nm fcc Cu nanocrystals, 10 minutes after synthesis and extraction from solution and (FIG. 10B ) X-ray powder diffraction patterns of 5 nm cuprite Cu2O nanocrystals, sample prepared after oxidation. -
FIG. 11 illustrates a synthetic procedure for Cu2O nanocrystals. -
FIGS. 12A-12C show transmission electron micrograph (TEM) of self-assembled 6 nm diameter Cu2O Nanocrystals (FIG. 12A ); TEM image showing a larger area view of a close-packed superlattice of 6 nm Cu2O nanocrystals (FIG. 12B) and high resolution image showing the single crystal and high crystallinity (FIG. 12C ).FIG. 12 D shows a selected area electron diffraction pattern of Cu2O nanocrystals. -
FIG. 13 shows UV-vis spectrum of as-prepared Cu2O nanocrystals in hexane at 298 K. -
FIGS. 14A-14B show transmission electron micrograph of 5.1±0.5 nm diameter Cu nanocrystal (FIG. 14A ) and corresponding 6.1±0.9 nm diameter Cu2O nanocrystal (FIG. 14B ), showing a 19.6% volume increase after oxidation; insert: Selected area electron diffraction pattern. -
FIG. 15 shows a plot of particle size vs the relative amount of oleic acid to copper (I) acetate, showing the diameter of the final product increases with a increased OA:Cu(Ac)2 ratio. -
FIG. 16 shows a stick and ball model of the crystal structure of cuprite Cu2O. - The present invention relates to methods of preparing nanoparticles (also referred to as nanocrystals herein) having size dependent nanocrystallite properties, including uniform size, monodispersity and stability over time, particularly in air and in nonpolar solvents. Magnetism is a further property possessed by a number of the nanoparticles of the present invention. This invention provides new synthetic routes to a prepare homologous sized series of monodisperse nanocrystals, which are monodisperse in terms of size, shape, internal structure and surface chemistry. In addition, the invention provides nanoparticles formed by the methods for use in a variety of different applications as described herein. As understood by the skilled practitioner, the term “nanocrystal” refers specifically to a crystalline nanoparticle, comprising an inorganic core of a single crystal of nanometer dimensions. The present invention encompasses both crystalline and non-crystalline metal oxide nanoparticles. The methods of the invention are particularly advantageous for producing nanoparticle products that are crystalline.
- Optical, electrical and magnetic studies of well-defined nanocrystal samples reveal the unique size-dependent properties of materials in this intermediate, nanometer size regime between molecular species and bulk solid. The present invention encompasses a newly-developed transition metal oxide system to produce nanostructured materials by virtue of a concerted synthetic, spectroscopic, and structural investigation. Methods for the preparation and systematic characterization of high quality nanocrystalline systems are provided. To distinguish true size dependent evolution from simple sample inhomogeneities and defects, a series of homologous samples spanning the size range of interest were produced as is described herein. When samples are nearly monodispersed, the ensemble average of the properties observed is representative of the properties of each individual crystallite. Thus, samples have been systematically synthesized and characterized using a combination of chemical and structural probes. By using generally-known procedures in the art, the structure and properties of these mesoscopic structures have been described with a precision that is comparable to many conventional macromolecules. When the individual nanocrystals and their properties are characterized and controlled, such nanocrystal building blocks are tailored into fundamentally new materials.
- One embodiment of this invention embraces a non-aqueous method for the synthesis of metal based nanoparticles, in particular, transition metal oxide nanoparticles. Suitable metal-based nanoparticles include, without limitation, zinc (Zn), iron (Fe), manganese (Mn), cobalt (Co), ruthenium (Ru), copper (Cu), scandium (Sc), titanium (Ti), vanadium (V), chromium (Cr), molybdenum (Mo), yttrium (Y), zirconium (Zr), hafnium (Hf), or nickel (Ni) metal-based nanoparticles, and mixtures thereof. Advantageously, these nanoparticles are capped with organic ligands. (e.g., alkyl chain capping groups) and are highly dispersible and stable in nonpolar solvents. Illustrative, yet nonlimiting, metal oxides prepared by the present methods include manganese oxide (MnO), iron oxide (FeO) and zinc oxide (ZnO), as well as more highly oxidized forms of one or more of these metal oxide nanoparticles.
- In accordance with the invention, the nanoparticles produced by the methods are relatively monodisperse, or uniform in size. Accordingly, the monodisperse nanoparticles of the invention are within less than 10% root mean square deviation (rms) diameter for spherical nanoparticles and less than 10% rms length or width for nanoparticle cubes and rods. The nanoparticles are also of the same shape—either all spheres, or cubes, or rods. The nanoparticles that can be made using the present methods include, but are not limited to nanorods, nanospheres, nanocubes, nanotriangles, nanobipods, nanotripods and nanotetrapods. The size, e.g., diameter, of the nanoparticles produced in accordance with the present invention can range from between about 2 nm and about 50 nm, or from about 3 nm to about 25 nm, or from about 6 nm to about 20 nm. Nanoparticle size can be achieved by controlling reaction parameters and/or conditions, as necessary or desired. For example, and as understood by the skilled practitioner, reaction parameters and/or conditions that may be controlled to achieve nanoparticles of different sizes include temperature, temperature heating and cooling rates, concentration of products, including solvent, ligand and metal precursor, heating and cooling times, and in particular, the time allowed for nanocrystal growth and the ratio of organic ligand to precursor. The nanoparticles generated according to the present methods are stable indefinitely under N2 and are stable in air for periods of several months.
- A unique feature and advantage of the present methods is the use of simple metal acetate precursors to prepare ligand-capped transition metal nanoparticles, e.g., MnO, FeO and ZnO, which are safer and more environmentally benign than are nanoparticles prepared from metal carbonyl materials. Other advantages afforded by the synthetic procedures for fabricating metal oxide nanoparticles according to the present invention include the following. First, the method is simple and reproducible, with typical yields of over 80%. Second, highly crystalline and monodisperse nanoparticles are obtained directly from the method without further size selection. A beneficial aspect of the present methods is that monodisperse nanoparticles are generated through its practice without a need for further manipulation, selection, or size-selective precipitations based on size. Such direct production of useful and high quality nanoparticles is another advantage afforded by the present invention. Third, particle size can be easily and fractionally increased by the present methods, thus allowing kinetic studies. Without intending to be bound by theory, the thermodynamics of the methods of the present invention and the reactions therein result in a separation of crystal nucleation from nanocrystal growth. Thus, all nanocrystals start to grow at the same time, spontaneously and homogeneously, resulting directly in substantially monodispersed and stable nanoparticles of uniform size. In one embodiment, the metal acetate precursor is anhydrous.
- The methods of the present invention provide the formation of virtually uniform sized nanoparticles having useful properties, such as light reflecting and absorbing properties for use in preventative or therapeutic products and formulations to prevent, reduce, retard, ameliorate, or eliminate photodamage and/or photoaging in a human or animal due to exposure to sunlight, such as in sunscreen formulations or compositions, suntan lotions or formulations and sunblock formulations or compositions. The nanoparticles also can have magnetic properties, which enhance their use in magnetic recording media, and read and write heads, as well as in a number of imaging and optical and electrical methods and devices. As but one example, the nanoparticles find use in the area of electrical field deposition technology for thin films, and in laser technology for laser materials.
- In addition, the nanoparticles according to the present invention are uniform in phase (crystal structure) and are coated with a surface passivating layer of organic molecules. The outer organic layer or coating, uniform size and composition allow the nanoparticles to cross the blood brain barrier, thus affording materials for formulating into biomedically-related useful therapeutic and/or preventive compositions, e.g., drugs and small molecules, for medical, dental and pharmaceutical uses. Such compositions can address a need in medicine and related arts to access medically and biologically important areas that are presently difficult to access. In medical or pharmaceutical formulations, the nanoparticles comprise compositions, which typically further include a pharmaceutically or physiologically acceptable carrier, diluent, vehicle, or excipient, such as physiologically sterile saline, or other physiologically acceptable injectable aqueous liquids, and the like.
- The above-mentioned properties of the nanoparticles prepared by the methods of this invention, e.g., organic coating and the like, provide further utilities for these materials in many types of commercially useful products such as cosmetics, foodstuffs, such as food powders, polymers, plastics, paints, industrial product formulations, etc. Cosmetics may include, without limitation, makeups, skin and body care products, such as topically-applied skin and body care products, soaps, powders, lotions, creams, ointments, conditioners, shampoos, fragrances, sunscreens, sunblocks, suntanning lotions, deodorants, deodorizers, hair colors and dyes. Topically applied and/or used products and product formulations are advantageously prepared. The optical and biochemical properties of zinc oxide nanoparticles can impart special features to a variety of cosmetic preparations for care of the hair and skin. In powders and creams ZnO nanoparticles can protect the skin by absorbing ultraviolet radiation that can lead to photoaging and skin damage; in burn ointments ZnO nanoparticles can aid healing.
- As a particular yet nonlimiting example, zinc oxide nanoparticles find utility in numerous applications in various industries. Some of all of these utilities also apply to others of the metal oxide nanoparticles according to this invention. For example, zinc oxide nanoparticles are useful in the rubber industry, such as in the particular areas of activation, acceleration, biochemical activity, dielectric strength, heat stabilization, latex gelation, light stabilization, pigmentation, reinforcement, rubber-metal bonding and tack retention. In addition, metal oxides, in particular zinc oxide, is useful in aspects of the plastics industry; in adhesives, mastics and sealants; in lubricants, such as in extreme-pressure lubricants, seizure-resistant lubricants, and greases; in photocopying processes, in which the presence of ZnO nanoparticles may result in increased photoconductivity and semiconductor properties by special heat and/or doping treatments (addition of foreign elements). Also, ZnO nanoparticles may be greatly modified in optical properties to increase the absorption of light rays in the visible region, a process known as sensitization, which is generally carried out by addition to certain dyes, which are absorbed on the surface of ZnO nanoparticles. Other useful aspects of metal oxide nanoparticles, such as ZnO nanoparticles of the present invention, include anti-corrosive properties in metal protective coatings, cigarette filters to remove selected ingredients from tobacco smoke; sulfur removal from certain fluids and gases, such as industrial flue gases; foods and food packaging materials, e.g., incorporation into the varnish linings of metal containers to prevent discoloration from food; flame retardants; ferromagnetic materials for electronic, television, radio, and tele-communication applications; batteries, fuel cells, photocells, thermoelements; components in silicate compositions to form waterproof, fireproof refractory materials, as a fungistat in fungicides to increase their effectiveness in certain formulations; and as a component of Portland cement involved in retardation of setting and hardening (to reduce the rate of heat evolution) and in improvement in whiteness and final strength of the cement product.
- In one embodiment, the present invention generally embraces a method of preparing monodisperse and stable metal oxide nanoparticles non-hydrolytically. The method comprises mixing a metal acetate precursor with a non-aqueous organic solvent comprising at least one organic stabilizer, or organic stabilizing ligand, to form a reaction mixture; heating the mixture at a temperature of greater than about 100° C., or at a temperature of from about 150° C. to about 450° C., or at a temperature of from about 150° C. to about 400° C., or at a temperature of from about 200° C. to about 380° C., or at a temperature of from about 250° C. to about 360° C., or at a temperature of from about 320° C. to about 350° C., for a time sufficient to allow the formation of metal oxide nanoparticles in organic solution, e.g., about 45 minutes to 1 hour, or about 1 hour. The reaction mixture is heated to the desired elevated temperature over a time period of from about 10 minutes to about 30 minutes, or from about 10 minutes to about 15 minutes, and the reaction is maintained at the elevated temperature for about 1 hour. The nanoparticles are then extracted into a hydrocarbon solvent under a cooler temperature, e.g., about 100° C. or less, typically at room temperature, e.g., from about 25° C. to about 60° C., by precipitation in a polar organic solvent, such as alcohols or ketones, also commonly referred to as flocculating agents or flocculents. In one embodiment, the metal acetate precursor is anhydrous.
- In a related aspect of the method, particles of different diameters can be obtained by first subjecting the organic solution to the elevated temperature as described, which results in obtaining a specific nanoparticle diameter, e.g., from about 4 nm to about 10 nm. This is followed by subjecting the organic solution comprising the nanoparticles to a second lower temperature of from about 100° C. to about 150° C., for a period of from about 5 minutes to about 60 minutes. At the second lowered temperature, nanoparticles of larger specific diameters, e.g., from about 10 nm to about 40 nm, are obtained. Accordingly, nanocrystals with increased diameter, e.g., as determined by TEM, can be obtained over time at the lower temperature. In one embodiment, the second lower temperature is about 100° C.
- An advantage of the methods of the invention is that the resulting metal oxide nanocrystals are coated with an organic material, e.g., an organic ligand, also referred to as ligand capping. The organic coating consists of organic molecules that act as capping agents for the surface, which is beneficial for their subsequent uses in a variety of applications, such as, for example, pharmaceutical compositions, cosmetics, and the like. Moreover, the transition metal oxide nanocrystals formed by the methods of the present invention are safer and more environmentally benign than their metal carbonyl counterparts.
- Without wishing to be bound by theory, in accordance with this invention, the reaction of a transition metal acetate in the organic solvent is believed to proceed via thermal decomposition of the acetate to a metal oxide-oleic acid complex, with the formation of CO2 and acetone by-products, aided by the elevated temperature.
- In accordance with the methods of this invention, the metal acetate precursor can include, without limitation, zinc (Zn) acetate, iron (Fe) acetate, manganese (Mn) acetate, cobalt (Co) acetate, ruthenium (Ru), copper (Cu) acetate, scandium (Sc) acetate, titanium (Ti) acetate, vanadium (V) acetate, chromium (Cr) acetate, chromium acetate dimer, molybdenum (Mo) acetate, molybdenum acetate dimer, yttrium (Y) acetate, zirconium (Zr) acetate, hafnium (Hf) acetate, nickel (Ni) acetate, or mixtures thereof. In further accordance with the invention, the metal acetate precursor is mixed with an organic solvent, which comprises at least one organic stabilizing ligand, which can have surfactant properties. In one embodiment, the metal acetate precursor is anhydrous.
- In general, the organic solvent used in the present methods is typically unreactive with respect to the formation of the nanoparticles, and has a boiling point of from about 150° C. to about 400° C. Thus, as would be appreciated by the skilled practitioner, any suitable solvent having a boiling point at the elevated temperatures as described herein and good solubility of the metal acetate precursor starting materials can be used. For example, other solvents include mineral oil, paraffin wax and polyethylene glycol. Alkylamine and ether (e.g., phenylether or n-dioctylether) solvents are used; an exemplary solvent for use is a trialkylamine. Trialkylphosphines can also be used. Trialkylamine solvents for use in the present methods have the formula [CH3(CH2)n]3N, where n is an integer ranging from 4 to 12. Typically trioctylamine, having the formula [CH3(CH2)7]3N, is used. In contrast to other methods, trialkylamines function as solvent in the methods of the present invention, rather than serving as both solvent and stabilizing ligand. Moreover, in the present methods, the solvent trialkylamines do not interfere with the reaction chemistry that leads to the formation of monodisperse, uniform nanoparticles. Thus, in general, the solvents per se are not directly involved in the formation of nanocrystals in the present methods.
- The organic solvent employed in the methods comprises one or more organic stabilizing agent or organic ligand. The one or more organic stabilizing ligands may also function as stabilizing agents. Suitable organic stabilizing ligands for use in the methods of this invention can be any long chain alkyl with one or more carboxylic acid functional group(s). These ligands typically have the formula CxHy[CO2H]z for integers x, y, and z that yield real saturated or unsaturated hydrocarbon chain carboxylic acid molecules, wherein x is an integer ranging from 6 to 30; z is an integer ranging from 1 to 3; and y is an integer ranging from 8 to 59. An example of such a carboxylic acid molecule is oleic acid of formula C17H33CO2H. Organic ligands can include, for example, long chain organic compounds expressed in the form R—X, in which “R” comprises either a straight or branched hydrocarbon or fluorocarbon chain having from 6 to 25 carbon atoms or 8 to 22 carbon atoms; and “X” comprises a moiety (“X”) which provides specific chemical attachment to the nanoparticle surface. Illustrative active groups include, without limitation, sulfonate (—SO2OH), sulfinate (—SOOH), phosphinate (—POOH), phosphorate (—OPO(OH)2), carboxylate, and thiol. Accordingly the resulting stabilizers include sulfonic acids (R—SO2OH), sulfinic acids (R—SOON), phosphonic acids (R2POOH), phosphoric acids (R—OPO(OH)2), carboxylic acids (R—COOH), thiols (R—SH), and mixtures thereof. In one embodiment, the organic stabilizer is a carboxylic acid. In a specific embodiment, the organic stabilizer is oleic acid.
- Oleic acid is known in the art as a surfactant stabilizer of colloids and has been used to protect iron nanoparticles. Oleic acid comprises a chain of 18 carbon atoms and is about 20 angstroms in length; it is not aliphatic and contains one double bond. The relatively long chain of oleic acid provides a major steric barrier to counteract the strong magnetic interaction between the particles. Oleic acid is advantageously used because it is inexpensive and easily available from natural sources, such as olive oil. Similar long chain carboxylic acids, such as erucic acid and linoleic acid, (e.g., any long chain organic acid with between 6 and 22 carbon atoms may be used alone or in combination) can also be used, in addition to, or instead of, oleic acid. Thus, oleic acid and oleylamine ligands surround the resulting nanoparticles; these ligands can be replaced, or added to, by other aliphatic acids and primary amines, as necessary or desired.
- With regard to the method in the above-described embodiment, a typical reaction involves the mixing of metal acetate and organic solvent containing at least one organic stabilizing agent as described above. The resulting mixture is heated rapidly, for a period of from about 10 minutes to about 30 minutes. In one embodiment, the mixture is heated for a period of from about 10 minutes to about 15 minutes. As a particular example, for a solution of manganese acetate, there is a color change to black during the rapid heating period. Thereafter, the solution is maintained at the elevated temperature for at least about 45 minutes, or about 1 hour, and typically under N2 flow, to yield uniform MnO nanocrystals. The method produces yields up to 80%. The nanocrystals are extracted at a lower temperature, e.g., from about 25° C. to about 60° C., into a hydrocarbon solvent, such as an alkane, including, but not limited to pentane, hexane, heptane, octane and dodecane, in particular, hexane, by precipitation in a polar organic solvent such as alcohols, e.g., methanol, ethanol, propanol, and butanol, or ketones, also referred to as flocculating agents (or flocculents). This is followed by centrifugation and redispersion in a hydrocarbon solvent, such as those mentioned above, e.g., hexane. (See, Example 1). Ethanol is a suitable precipitating agent. The nanocrystals resulting from the method are characterized using transmission electron microscopy (TEM) and X-ray powder diffraction (XRD), e.g., as described in Example 1 and shown in
FIGS. 1A and 1B andFIGS. 2A-D for MnO nanocrystal formation. - In another embodiment, the nanoparticles produced by the methods of the invention can be deposited onto a solid surface following precipitation and dispersion. The deposited nanoparticle dispersion is dried; drying is conveniently performed at room temperature. Thus, in accordance with this embodiment, monodisperse particle thin films are provided, such as can be used for the many aspects as described herein, e.g., ultra-high density recording media. Suitable solid surfaces or flat substrates include, without limitation, SiO2, Si, glass or carbon, for the preparation of thin films. This is especially useful for magnetic metal particles, which are surrounded by protective ligands, and which produce magnetic particle thin films. Annealing of the particle dispersion to the thin film can comprise temperatures of from about 500° C. to about 600° C. and produces mirror-like thin films; such films can have controlled coercivities, e.g., of from about 500 Oe to about 6500 Oe.
- In another embodiment related to the specific transition metal oxide, manganese oxide (MnO), monodisperse and uniform nanocrystals of 7 nm in length were synthesized by thermal decomposition of manganese acetate in the presence of oleic acid at high temperature. (See Example 1). The method of this embodiment involves mixing manganese acetate precursor, e.g., at room temperature (e.g., 25-60° C.), with an organic solvent including at least one organic stabilizing ligand as described herein, e.g., a sulfonic acid, a sulfuric acid, a phosphonic acid, a phosphoric acid, a carboxylic acid, or a thiol, to form a reaction mixture in a non-aqueous environment. Suitable organic stabilizing ligands are carboxylic acids, such as oleic acid. Exemplary organic solvents include, without limitation, trialkylamines, such as trioctylamine or trimethylamine-N-oxide. The mixture is then heated to a temperature of from about 300° C. to about 350° C., and maintained at the elevated temperature for a time sufficient to allow the formation of monodisperse manganese oxide nanoparticles in organic solution and decomposition of the manganese acetate. In one embodiment, the time sufficient is from about 45 minutes to about 1 hour. In another embodiment, the time sufficient is about 1 hour. In one embodiment, the mixture is heated at about 320° C. In an exemplary aspect, after about 1 hour at the high temperature, the organic solution is cooled to a temperature lower than the reaction temperature, i.e., to about 100° C., which results in a gradual increase in crystal size. The manganese oxide nanoparticles are then extracted into a hydrocarbon solvent, e.g., an alkane such as hexane, by precipitation in alcohol, e.g., ethanol, followed by centrifugation and redispersion. The resulting extracted monodisperse manganese oxide (MnO) nanoparticles have a uniform size, e.g., from about 6 nm to about 20 nm, or from about 12 nm to about 20 nm, or from about 6 nm to about 7 nm, and are monodisperse and stable to oxidation over time. In addition, the resulting manganese oxide nanoparticles are ligand-capped due to the organic solvent components, thus resulting in an organic outside coating. In one embodiment, the manganese acetate precursor is anhydrous.
- In a related embodiment, the above-described monodisperse MnO nanoparticles are further oxidized to obtain Mn3O4 nanoparticles. The oxidation comprises exposing the manganese oxide particles to air or chemical oxidation to obtain further oxidized Mn3O4 nanoparticles. For chemical oxidation, the manganese oxide particles can be exposed to trimethylamine-N-oxide to obtain ligand-capped Mn3O4 nanoparticles. (See, e.g., Example 1). The resulting Mn3O4 nanoparticles are also monodisperse and uniform in size and can comprise a nanocrystal size of from about 3 nm to about 20 nm, e.g., about 7 nm.
- Mn3O4 has applications in its pure form as one of the raw materials in the manufacture of professional grade ferrites, which find use in electronic industries. Manganese oxides are also appealing for use in lithium-ion cells, as manganese is inexpensive and environmentally benign. Other uses for Mn3O4 produced in accordance with the methods of this invention include electrode materials for rechargeable lithium batteries; corrosion inhibiting pigments for epoxy-polyamide and epoxy-ester-based primers and top coatings; starting material for the manufacture of soft magnetic materials such as manganese zinc ferrite, which is useful for magnetic cores in transformers for power supplies; and in the manufacture of welding rods and fluxes.
- Exchange spring magnets, which are composed of a two phased distribution of hard- and soft-magnetic grains, have potential application as permanent magnets. An Fe3O4/Mn3O4 superlattice is a strong candidate for such types of magnets. The hard-magnetic grains provide the high anisotropy and coercive fields, while the soft magnetic grains enhance the magnetic moments. The soft grains are pinned to the hard-magnet grains at the interfaces by the exchange interaction, while the center of the soft-magnet grains can rotate in a reversed magnetic field. Such magnets are characterized by enhanced remnant magnetization and reversible demagnetization curves, since the soft grains will rotate back into alignment with the hard grains when the applied field is removed. A superlattice, which consists of a series of repeatedly stacked layers with a substantially enhanced interface effect, is an ideal system for the interface studies. In accordance with the methods presented herein, the preparation of a Fe3O4/Mn3O4 superlattice, or a superlattice thin film, is encompassed, because the Fe3O4 and Mn3O4 components have very different magnetic anisotropies and coupling strengths. In such superlattices or thin films, the Mn3O4 component may significantly improve the performance of ferromagnetism due to its spring exchange or couple exchange. Also, Mn3O4 nanoparticles formed according to the methods described herein can be used in magnetoresistive materials, e.g., colossal magnetoresistive materials. For example, magnetoresistive oxide thin films comprising, for example, Mn3O4 can be made using electrical field deposition technology.
- In another embodiment, the present invention encompasses a method for forming monodisperse, uniformly sized, and stable nanoparticles of iron oxide (FeO). The method involves mixing iron acetate precursor, e.g., Fe(II)acetate, with an organic solvent, e.g., at room temperature (e.g., 25-60° C.), to form a reaction mixture, which is non-aqueous. The organic solvent includes at least one organic stabilizing ligand, e.g., sulfonic acid, sulfuric acid, phosphonic acid, phosphoric acid, carboxylic acid, or thiol. Suitable organic stabilizing ligands include carboxylic acids, such as oleic acid. Organic solvents including trialkylamines, e.g., trioctylamine or trimethylamine-N-oxide, are suitable for use in the present methods. The mixture is then heated to a temperature of from about 200° C. to about 260° C., preferably, about 250° C., and maintained at the elevated temperature for a timer period of from about 45 minutes to about 1 hour, i.e., a time sufficient to allow the formation of monodisperse iron oxide nanoparticles in organic solution and decomposition of the iron acetate. The iron oxide nanoparticles are then extracted into a hydrocarbon solvent, e.g., an alkane such as hexane, by precipitation in non-polar solvent, such a alcohol, e.g., ethanol, centrifugation and redispersion. The resulting extracted monodisperse iron oxide (MnO) nanoparticles have a uniform size, e.g., about 3 to about 20 nm, or from about 12 to about 20 nm, or 7 nm, and are stable to oxidation over time. The resulting iron oxide nanoparticles are further ligand-capped, thus resulting in an organic outside coating, which provides the aforementioned advantages for a use in pharmaceutical, medically-related, or cosmetic compositions, as well as one or more of the above-described industrial applications, as but a few illustrative examples. In one embodiment, the iron acetate precursor is anhydrous.
- In an embodiment related to another transition metal oxide, the present invention embraces a method for forming monodisperse, uniform and stable nanoparticles of zinc oxide (ZnO). The method of this embodiment involves mixing zinc acetate precursor, e.g., at room temperature (e.g., 25-60° C.), with an organic solvent, e.g., a trialkylamine, including at least one organic stabilizing ligand, e.g., a sulfonic acid, a sulfuric acid, a phosphonic acid, a phosphoric acid, a carboxylic acid, or a thiol, to form a reaction mixture in a non-aqueous organic solution. Suitable organic stabilizing ligands include carboxylic acids, such as, for example, oleic acid. Other suitable organic solvents include trialkylamines, such as trioctylamine or trimethylamine-N-oxide. The mixture is then heated to a temperature of from about 320° C. to about 400° C., preferably, about 360° C., and maintained at the elevated temperature for a time period of from about 45 minutes to about an hour, i.e., a time sufficient to allow the formation of monodisperse zinc oxide nanoparticles in organic solution and decomposition of the zinc acetate. The zinc oxide nanoparticles are then extracted into a hydrocarbon solvent, e.g., an alkane such as hexane, at a temperature lower than that of the heating temperature, e.g., 100° C., by precipitation in a polar organic solvent such as an alcohol, e.g., ethanol, or flocculating agent (or flocculent), followed by centrifugation and redispersion. The resulting extracted monodisperse zinc oxide (ZnO) nanoparticles have a uniform size, and are stable to oxidation over time. The resulting zinc oxide nanoparticles are further ligand-capped due to the organic solvent components, thus resulting in an organic outside coating. In one embodiment, the zinc acetate precursor is anhydrous.
- In a related embodiment, the above method is employed for the formation of zinc oxide nanorods, which are uniform in size, e.g., 2-3 nm×30-40 nm, and can be used in a variety of applications as described below. In accordance with the above-described method using anhydrous zinc acetate starting material, both spherical nanoparticles and nanorods (i.e., rods with diameters of 2-10 nm and aspect ratios in the range of 1:5 and up to 1:40) can be prepared. Without being bound by theory, this is due to the asymmetric crystal structure of zinc oxide. For the generation of spheric nanoparticles, the zinc acetate:surfactant ratio is 1:3 or greater; for the generation of nanorod nanoparticles, the zinc acetate:surfactant ratio is less than 1:2. The preparation of rods or spheres of zinc oxide depends on the reaction conditions, including choice of ligand and/or organic solvents, such as trioctylamine for rods and 1-hexadecanol or 1-octadecene for spheres.
- An application for ZnO nanoparticles prepared according to the methods of the present invention include serving as a material for the emission of ultra-violet light, i.e., as a substitute for GaN, a well-known UV laser material. ZnO may also be used for optoelectronic applications in the short wavelength range (green, blue, UV). In fact, the high exciton binding energy in ZnO (about 60 meV vs. 25 meV for GaN) would allow for excitonic transitions even at room temperature, which could mean a higher radiative recombination efficiency for spontaneous emission, as well as a lower threshold voltage for laser emission.
- ZnO has several fundamental advantages over the use of GaN: (1) the free exciton of ZnO is bound with 60 meV, much higher than that of GaN (21-25 meV); (2) ZnO has a native substrate; (3) wet chemical processing of ZnO is possible; and (4) ZnO is more resistant to radiation damage, for example, compared with Si or GaAs, which are poor performers for radiation damage. ZnO epitaxy layers can also serve as very suitable materials for photonic devices in the ultraviolet region. The use of semiconductor quantum well structure as a low-threshold optical gain medium represents a sizable advancement in semiconductor laser technology. There is a need in the art to find materials and ways to deposit high-quality c-axis oriented thin films at modest substrate temperatures; ZnO nanoparticles produced according to the present methods can address this need. In particular, electrical field deposition technology can be used to produce thin films comprising ZnO nanoparticles, including ZnO nanorods, according to the present invention.
- In another embodiment, the present invention encompasses compositions comprising the above-described metal oxide nanocrystals for use in cosmetic formulations and compositions. Such cosmetic formulations and compositions include, without limitation, makeups, skin and body care products, such as topically-applied skin and body care products, powders, lotions, creams, ointments, conditioners, shampoos, fragrances, sunblocks, sunscreens, suntanning lotions, deodorants, deodorizers, and hair colors and dyes. Topically-applied products and product formulations are advantageous. Nonlimiting examples of skin care formulations that may contain the nanoparticles of the invention are found, for example, in U.S. Pat. No. 6,168,798 to O'Halloran, and U.S. Pat. No. 5,885,596 to P. Parab.
- In another embodiment, the present invention encompasses pharmaceutical and medical formulations and compositions comprising the above-described metal oxide nanocrystals. The outer organic coating, which is comprised of organic molecules that act as capping agents for the surface of the nanoparticles of the invention, endow the nanoparticles with the beneficial and clinically relevant property of crossing the blood/brain barrier. Such pharmaceutical and medical formulations and compositions typically include a physiologically or pharmaceutically acceptable carrier, diluent, excipient, or vehicle, typically comprising a suitable liquid or solution such as sterile physiological saline or other physiologically acceptable injectable aqueous liquids.
- For injectable administration, compositions comprising the nanoparticles can be prepared in sterile solution or suspension, or resuspended in pharmaceutically- and physiologically-acceptable aqueous or oleaginous vehicles, which may contain preservatives, stabilizers, and material for rendering the solution or suspension isotonic with body fluids (i.e. blood) of the recipient. Non-limiting examples of excipients, diluents, vehicles, or carriers suitable for use include water, phosphate buffered saline (pH 7.4), 0.15M aqueous sodium chloride solution, dextrose, glycerol, dilute ethanol, and the like, and mixtures thereof. Illustrative stabilizers are polyethylene glycol, proteins, saccharides, amino acids, inorganic acids, and organic acids, which may be used either on their own or as admixtures. The amounts or quantities, as well as the routes of administration used, are determined on an individual basis, and correspond to the amounts used in similar types of applications or indications known to those of skill in the art.
- The examples described below are provided to illustrate the present invention and are not included for the purpose of limiting the invention.
- An example of the synthesis procedure to produce metal oxide nanocrystals according to the present invention is provided. In this Example, the formation of MnO nanoparticles is described. To carry out this reaction, 4 mmol of dry manganese acetate (Mn(CO2CH3)2, Aldrich) was added to a mixture containing 15 ml of trioctylamine and 3 g of oleic acid (12 mmol) at room temperature. The resulting mixture was heated rapidly to 320° C. over 10 to 15 minutes; during this time, the solution gradually changed to black. The solution was maintained at 320° C. for 1 hour under N2 flow to yield uniform MnO nanocrystals with yields of up to 80%. The nanocrystals were cooled to room temperature, 25-60° C., and extracted into hexane by precipitation with ethanol in an amount between 5-200% volume of the original volume in the reaction vessel. As understood by the skilled practitioner, the extraction temperature was, in general, a temperature cooler than the reaction/heating temperature. In some instances, a temperature of less than 200° C. was used, for example, 100° C. Next, the extracted, precipitated material was centrifuged for 5-100 minutes at about 3000-6000 rpm and redispersed into hexane solvent.
- The resulting nanocrystals were characterized using transmission electron microscopy (TEM), (JEOL, 100cx, acc. 100 kV) and X-ray powder diffraction (XRD, Scintag X2). TEM samples were prepared by placing a drop of a dilute hexane dispersion of nanocrystals on the surface of a 400 mesh copper grid backer with Formvar and were dried in a vacuum chamber at 80° C. for 1 hour. XRD samples were prepared by drying a dispersion of nanocrystals on a piece of Si (100) wafer. The XRD spectrum (
FIG. 1A ) exhibited the highly crystalline peaks that could be matched to the series of Bragg reflections corresponding to the standard and phase pure cubic rock salt structure of MnO (Fm3m, a=4.442 angstroms). The particle size, calculated from the Debye-Scherrer equation, was 6.8 nm, confirmed by average 7 nm diameters in the TEM. Nanocrystal assembly from hexane solutions into closed packed arrays was also observed, thus demonstrating the uniformity of the particle size and retention of the oleic acid capping group. - Controlling evaporation conditions, e.g., by using a closed system at room temperature and allowing for diffusion to remove the solvent over periods of from 1-10 hours, allowed for the formation of a three-dimensional close-packed superlattice assembly of 14 nm MnO nanocrystals (
FIG. 2B ). Selected area electron diffraction patterns (SAED) of all samples indicated a highly crystalline rock salt structure, in good agreement with XRD (FIG. 1B ). Monodisperse MnO nanoparticles of from about 12-20 nm in size were prepared as described above, and an annealing step was further performed after the temperature was kept at 320° C. for 1 hour by carefully cooling the resulting solution to 100° C. (FIGS. 2A-2D ). Nanocrystals with increasing diameter gradually grew at the lower temperature. Selected area electron diffraction patterns confirmed the MnO structure. Particle size was determined and cross-referenced by XRD Debye-Scherrer analysis and TEM. An increase in cubic faceting of the nanocrystals was observed with an increase in size. (FIG. 2E ). The average increase in size of the MnO nanocrystals was followed using TEM with time to prepare samples with average diameters of 12, 14, 18 and 20 nm after 5, 10, 30 and 60 minutes, respectively. (FIG. 6A ). - A quantitative assessment of the growth kinetics of transition metal oxide nanocrystals was performed using the Lifshitz-Slyozov-Wagner (LSW) model. (G. Oskam et al., 2003, J. Phys. Chem. B, 107:1734; I. M. Lifshitz et al., 1961, J. Phys. Chem. Solids, 19:35; C. Z. Wagner, 1961, Elektrochem., 65:581). Particle growth is driven by the dependence of the solubility of a solid phase on the particle size according to the Gibbs-Thomson equation. (X. Peng et al., 1998, J. Am. Chem. Soc., 120:5343). Assuming that the particles are spherical, the solubility, Cr, of a particle with radius r is given by the following equation:
-
- where c∞ is the solubility at a flat surface, γ is the surface energy of the solid, Vm is the molar volume, R is the gas constant, and T is the temperature. For the case where (2γVm/rRT)<1 such that the exponential term in
equation 1 can be linearized, and assuming that the growth rate is determined by diffusion of the solute from the smaller particles to the larger particles, the following rate law is obtained (G. Oskam et al., 2003, J. Phys. Chem. B, 107:1734; I. M. Lifshitz et al., 1961, J. Phys. Chem. Solids, 19:35; C. Z. Wagner, 1961, Elektrochem., 65:581): -
- where r is the particle radius at time t and r0 is the particle radius at time zero. (X. Peng et al., 1998, J. Am. Chem. Soc., 120:5343).
FIG. 6B shows the cube of the particle radius plotted versus time. It can be inferred from the roughly linear dependence that the increase in particle size is dominated by diffusion-limited growth at this temperature. The intercept at t=0 corresponds to the particle size (7 nm) of the as-prepared sample. - To extend the above experimental procedure to a wider range of binary transition metal oxides, chemical oxidation of 7 nm MnO nanocrystals with trimethylamine-N-oxide, [CH3]3NO, formed uniform and ligand-capped 7 nm nanocrystals of Mn3O4 (hausmannite structure, I4I/amd, a=5.762 angstroms, c=9.470 angstroms), as characterized by TEM and XRD. (
FIGS. 3A-3C ). (See, e.g., T. Hyeon et al., 2001, J. Am. Chem. Soc., 123:12798). In this aspect, stoichiometric ratios were in the range of 2-6 times the molar ratio of oxidant:metal precursor, e.g., 1 Mn(CH3CO2)2:4[CH3]3NO. In addition, highly uniform preparations of ligand-capped nanocrystals of FeO (Wurstite structure, Fm3m) of 14 nm in size were formed using the method as described for MnO, by substituting Fe(II) acetate as the precursor. Following this method, magnetic measurements showed that the as-synthesized MnO and Mn3O4 nanoparticles were superparamagnetic at room temperature, as determined on a superconducting quantum interference device (SQUID) with typical fields and temperatures of 2-300° K. (FIGS. 4A-4E , MnO;FIGS. 4C-4I , Mn3O4). (See, e.g., M. Yin and S. O'Brien, 2003, J. Am. Chem. Soc., 125:10180-10181). - This Example describes the formation of FeO nanoparticles prepared using the new synthesis according to the present invention. This method affords better control of the oxidation states of iron. In the method, dehydrated iron acetate (i.e., Fe2+ salt) was used as the iron precursor and monodispersed, metastable wustite phase FeO nanocrystals were synthesized. In the reaction, dry iron acetate was mixed with trioctylamine organic solvent (10-20 mL) containing oleic acid as surfactant/stabilizing ligand (2-5 mL), and the mixture was heated over 10 to 15 minutes to a temperature of 250° C. The reaction was kept at this temperature for 1 hour under N2. Thereafter, the FeO nanoparticles were cooled to 100° C., and were extracted into hexane by precipitation with ethanol, followed by centrifugation and redispersion in hexane as described hereinabove. The resulting nanocrystals were characterized using TEM (JEOL, 100cx, acc. 100 kV) and X-ray powder diffraction (XRD, Scintag X2), as described in Example 1. Further oxidized forms of iron oxide, e.g., Fe2O3 and Fe3O4, nanoparticles were prepared using oxidizing agents in the synthetic process. Trimethylamine N-oxide is one example of an oxidizing agent that can be used in this example. Other oxidants include pyridine N-oxide (C5H5NO), phenyl sulfoxide (C12H10SO) and dimethyl sulfoxide ([CH3]2SO). After the FeO particles were prepared, the solution was cooled to room temperature, and then oxidants were added. Thereafter, the temperature was again raised to 200-300° C. and the FeO nanoparticles were oxidized to a higher oxidation status, i.e., Fe3O4 or Fe2O3. Both forms of iron oxide have superior magnetic properties.
- This Example describes the formation of Cu2O nanoparticles prepared using the synthesis methods according to the present invention. This method affords better control of the formation of Cu2O and further oxidation to CuO nanoparticles. Using the method of the invention, rated copper acetate was used as the copper precursor and monodispersed, metastable cuprite phase Cu2O nanocrystals (2 nm to 50 nm) were synthesized. The copper acetate starting material was mixed with a trioctylamine organic solvent containing oleic acid and was heated to 280° C. over a 10 to 15 minute time period. The reaction was maintained at the high temperature for about 1 hour under N2. The reaction vessel was cooled to room temperature, and copper oxide nanocrystals were extracted into hexane by precipitation with ethanol, followed by centrifugation and redispersion in hexane as described above. The resulting Cu2O nanoparticles were analyzed by XRD and TEM as shown in
FIGS. 9A-9G . Further oxidized CuO nanoparticles could also be prepared by further oxidation of Cu2O nanoparticles by using the oxidants described in Example 2. Such copper oxide nanoparticles are suitable for use as material comprising solar batteries, for example. - Copper Oxide Nanocrystals: Inorganic nanocrystals are a benchmark model for nanotechnology, given that the tunability of optical properties, and the stabilization of specific phases are uniquely possible at the nanoscale. As discussed herein, copper (I) oxide (Cu2O) is a metal-oxide semiconductor with promising applications in solar energy conversion and catalysis. To understand the Cu/Cu2O/CuO system at the nanoscale, the invention provides a method for preparing highly uniform monodisperse nanocrystals of Cu2O. The synthetic procedure serves to demonstrate our development of a generalized method for the synthesis of transition metal oxide nanocrystals, which involves thermal decomposition of metal acetate-surfactant complexes in hot organic solvents. In this case Cu nanocrystals are formed and are subsequently oxidized to form highly crystalline copper (I) oxide, Cu2O. Interestingly, the transformation of Cu nanocrystals to Cu2O can induce crystal twinning. This invention is based on a surprising discovery that the copper (I) oxide phase is well-stabilized at this lengthscale.
- Copper (I) oxide (Cu2O) is a p-type metal-oxide semiconductor with promising applications in solar energy conversion and catalysis. (1-4, wherein the numbers in parenthesis for Example 3 refer to references as set forth below herein). There is much interest in Cu2O, also called cuprous oxide, due to its rich excitonic structure. The large excitonic binding energy (140 meV) allows the observation of a well-defined series of excitonic features in the absorption and luminescence spectrum at low temperature, (5,6) yet studying quantum confinement effects or modifying the behavior of the direct forbidden band gap is challenging. (7,8) It is also a useful compound to study the influence of electron-correlation effects on the electronic structure of transition metal compounds in general, and the high Tc superconductors in particular. (2) Although the absorption characteristics of the various exciton series for copper (I) oxide have been studied. (5,9-13) Most samples have been limited to bulk, micro sized or nanopowders. The invention provides for a procedure by which discrete, monodisperse and uniform nanocrystals of pure copper are extracted from solution, which can be completely oxidized to Cu2O. Cu2O is a prospective candidate for low-cost photovoltaic applications due to its high optical absorption coefficient, lower band gap energy (2.2 eV), and simplicity of preparation, scalability, the non-toxic nature, the abundance and the economics of the material. Further opportunities in catalysis could be realized through the preparation of self-assembled nanostructures and stabilization of specific phases of copper oxide. Therefore, it is of interest to prepare high quality, monodisperse copper oxide nanocrystals, to examine their structure and characterize their optical properties. An investigation and understanding of size effects in such a system is of interest due to the possibility of tuning its opto-electronic properties. Substantial effort has been devoted to the Cu/Cu2O/CuO system in the 1-500 nanometer range. (14-18) The approach of the present invention involves thermal decomposition of copper (I) acetate at high temperature, in the presence of a surfactant. This results in highly monodisperse and crystalline nanoparticles of Cu2O, with a mean particle size tunable from 3.6±0.8 nm to 10.7±0.7 nm (based upon the stoichiometric ratio of surfactant to copper precursor). Evidence of Cu2+ in the XPS and optical characterization of the nanocrystals suggested the existence of a thin layer of CuO at the nanocrystal-ligand interface.
- Crystals of a finite size assume a modified morphology and/or crystal structure in order that the atoms, especially those at the surface, can adopt the most stable equilibrium configuration of minimal energy. (2) Consequently, some materials, which are not stable in bulk and do not exist in ambient atmosphere, may become substantially more stable at the nanoscale. This is due to the large contribution of surface energy which can stabilize the origin of unique phases. (19-21) Bulk Cu2O, with a cuprite structure, absorbs oxygen from the air and can readily convert to CuO at room temperature. (2)
- The synthetic procedure used for the Cu/Cu2O/CuO system serves to illustrate our development of a generalized method for the synthesis of transition metal oxide nanocrystals, which involves metal acetates as the precursors and thermal decomposition of metal acetate-surfactant complex in a hot organic solvent. (23,24) In some places herein and elsewhere this method is termed “TDMA” (thermal decomposition of metal acetates). The method is effective for the synthesis of 1st row transition metal and transition metal oxide nanocrystals (
FIG. 11 ). (25) The method of the invention insures the preparation of highly uniform, monodisperse nanocrystals of Cu2O in high yield (typically >50-60% wrt conversion of precursor). Synthesis of transition metal oxide nanocrystals by choosing their acetates as precursors is simple and relatively safe. (23,24) The experiments performed show that generally, the standard deviation of the size of nanocrystals prepared with solvent degassing (to remove O2) is less than 5%, without further size selection. The as-synthesized nanocrystals have a capping coordination sphere of oleic acid, which stablilizes them in solution, prevents aggregation and allows them to form close packed superlattice structures following evaporation of the solvent. - In order to obtain evidence that the nanoparticles formed in situ are initially pure copper nanocrystals, X-ray powder diffraction was performed immediately after sample preparation. The peaks in the XRD could be indexed to the fcc structure of metal copper (Fm-3m, a=3.615, JCPDF #85-1326) (
FIG. 10A ). Only a very small peak of Cu2O (110) was detected (and was also observed to grow slightly during XRD measurement), ascribed to nanocrystal oxidation post synthesis. After precipitation, if the nanoparticles are dissolved in hexane and exposed to air, the color of the nanoparticle solution turns to dark green, commensurate with oxidation to Cu2O. XRD of this nanocrystal sample show that all of the peaks match well with Bragg reflections of the standard cubic cuprite structure (Pn-3m, a=4.258 Å, JCPDF #78-2076) as shown inFIG. 10B . The process of full oxidation from Cu to Cu2O nanocrystals can take up to a few hours depending on the conditions and particle size but in all cases transformation to Cu2O is complete, in contrast to previous reports. (17) The crystal structure of Cu2O is cuprite, which is composed of 8 cubes, as shown in s-FIG. 16 . In each cube, Cu atoms occupy all the fcc positions and two oxygen atoms occupy two diagonal tetrahedral interstices. The oxidation can be qualitatively interpreted as an oxygen diffusion and lattice expansion process. When Cu nanocrystals are exposed to air, electrons are transferred from Cu atoms to oxygen and the oxygen anions produced diffuse in the tetrahedral interstices. As a result, the crystal structure and material changes from fcc Cu to cuprite Cu2O with a corresponding lattice expansion (seeFIGS. 12-15 ). Cu and Cu2O share the high-symmetry cubic structure, while CuO is a low-symmetry monoclinic structure. The oxidation transition to Cu2O is accomplished by oxygen atoms' diffusion into tetrahedral interstices and lattice expansion. However, there is a considerable energetic difference between the fcc structure (Cu) and monoclinic structure (CuO), as atom rearrangement and lattice/unit cell reconstruction is required, which may help to explain why the transformation to crystalline CuO does not occur in these nanocrystals. Detailed structural analysis presented here reveals the presence of Cu2+ ions predominately at the surface, attributed to a thin layer of amorphous CuO which may also serve as a kinetic stabilization with respect to further oxidation. The results presented here are consistent with other observations of Cu2O stability at the nanoscale. (22) - Nanocrystal assembly from hexane solutions into closed packed arrays was also observed in
FIGS. 12A , and 13A, demonstrating the uniformity of the particle size and retention of the oleic acid capping group.FIG. 12B shows a view of a close-packed superlattice of 6 nm Cu2O nanocrystals. The nanocrystals are clearly suitable candidates for the preparation of binary superlattice structures. (26) If the particle is oriented along a low-index zone axis, the distribution of atoms on can be imaged.FIG. 12C gives a profile HRTEM image of cubic Cu2O nanocrystals. The lattice plane distance is 1.88 Å, indicating (2 1 0) planes. Selected area electron diffraction patterns (FIG. 12D ) can be indexed to cubic symmetry, indicating cubic crystal structure of Cu2O. - The role of the capping ligand is very important to nanocrystal synthesis, during nucleation, growth and stabilization of the particles post-synthesis with respect to agglomeration and stabilization in organic solvents. A decrease of particle size from 10.7±0.7 nm to 3.6±0.8 nm was observed as the molar ratio of copper (I) acetate to oleic acid was increased from 0.08 to 0.6 (supporting information,
FIG. 15 ). The ability of controlling particle size is of interest to prepare high quality, monodisperse cuprous oxide nanocrystals and to characterize their optical properties. - Monodisperse, stable Cu2O nanocrystals were synthesized by using a novel, yet simple wet chemistry route. This method gives a high yield of nanocrystals and narrow size distribution. The Cu2O nanocrystal size could be controlled from 3.6 nm to 10.7 nm by controlling the molar ratio of oleic acid to copper precursor. From structural analysis, it was concluded that the Cu2O phase is highly stabilized in these nanocrystals. The investigated Cu2O nanocrystals show a band gap transition. In addition, they display a band gap transition of the surface CuO layer. XPS reveals an amorphous layer of CuO on the Cu2O nanocrystal surface and the reduction of surface CuO to Cu2O by X-ray irradiation.
- Nanocrystal Synthesis—Copper (I) acetate (CH3CO2Cu), trioctylamine ([CH3(CH2)7]3N), oleic acid (CH3(CH2)7CH═CH(CH2)7CO2H), hexane, and ethanol were purchased from Aldrich and used as received. In a typical synthesis, a solution containing 4 mmol copper acetate, 4 ml oleic acid and 15 ml trioctylamine was quickly heated to 180° C. under Nitrogen, the color gradually changed from forest green to coffee, finally producing a gray colloid. The presence of oxygen or water is highly undesirable during the decomposition and nucleation stage. The solution was kept at this temperature for 1 hour. Then, it was quickly heated up to 270° C. The gray colloid gradually changed to a deep burgundy solution. The solution was kept at 270° C. for an hour before it was cooled down to RT (room temperature), and particles were precipitated by ethanol and redispersed in hexane. The particles (Cu) are observed to be initially dark red, forming a purple/dark-red solution when dispersed in hexane. The resulting red purple copper particles gradually oxidize to Cu2O in hexane, and produce a deep green solution. The final Cu2O nanocrystals were very stable in hexane, both with respect to oxidation and agglomeration, and ready to be used for further experiments.
- TEM and XRD characterization—Cu2O nanocrystals were characterized using transmission electron microscopy (JEOL CX100) with an accelerating voltage of 100 kV, high resolution TEM (JEOL 3000F) with an accelerating voltage of 300 kV, and X-ray powder diffraction (Scintag X2 X-ray diffractometer). TEM samples were prepared by placing a drop of a dilute hexane dispersion of nanocrystals on the surface of a 400 mesh copper grid backed with Formvar, and were dried in a vacuum chamber for 1 hr. JEOL 3000F was used for lattice imaging. XRD samples were prepared by drying a dispersion of nanocrystals on a piece of Si (100) wafer.
- UV-Vis characterization—The UV-vis absorbance and fluorescence spectra were measured on a
Varian Cary 50 and a Varian Eclipse fluorescence spectrophotometer, respectively. XPS characterization. The XPS experiment was performed on PHI 5500 model spectrometer equipped with an Al KR monochromator X-ray source running at 15 kV and 23.3 mA, a hemispherical electron energy analyzer, and a multichannel detector. The test chamber pressure was maintained below 2×10−9 Torr during spectral acquisition. A low-energy electron flood gun was used to neutralize the possible surface charge. The XPS binding energy (BE) was internally referenced to the aliphatic C(1s) peak (BE, 284.6 eV). Survey spectra were acquired at an analyzer pass energy of 93.9 eV and BE resolution of 0.8 eV, while high resolution spectra were acquired with a pass energy of 23.5 eV and BE resolution of 0.05 eV. The takeoff angle is defined as the angle between the surface normal and detector. High-resolution spectra were resolved by fitting each peak with Guassian-Lorentz functions after subtracting the background using the PHI data processing software package under the constraint of setting a reasonable BE shift and characteristic full width at half-maximum range. Atomic concentrations were calculated by normalizing peak areas to the elemental sensitivity factor data provided by the PHI database. -
- (1) Dong, Y.; Li, Y.; Wang, C.; Cui, A.; Deng, Z. J. Colloid. Interface Sci. 2001, 243, 85-89.
- (2) Ram, S.; Mitra, C. Mater. Sci. Eng. 2001, A304-306, 805-809.
- (3) Musa, A. O.; Akomolafe, T.; Carter, M. Solar Energy Mater. Solar Cells 1998, 51, 305-316.
- (4) Bohannan, E. W.; Shumsky, M. G.; Switzer, J. A. Chem. Mater. 1999, 11, 2289-2291.
- (5) Deki, S.; Akamatsu, K.; Yano, T.; Mizuhata, M.; Kajinami, A. J. Mater. chem. 1998, 8, 1865.
- (6) Caswell, N.; Yu, P. Y. Phys. Rev. B. 1982, 25, 5519.
- (7) Borgohain, K.; Murase, N.; Mahamuni, S. J. Appl. Phys. 2002, 92, 1292.
- (8) Amikura, H.; Masumi, T. J. Phys. Soc. Jpn. 1995, 64, 2684.
- (9) Trebin, H. R.; Cummins, H. Z.; Birman, J. L. Phys. Rev. B. 1981, 23, 597.
- (10) Gastev, S. V.; Kaplyanskii, A. A.; Sokolov, N. S. Solid State Commun. 1982, 42, 389.
- (11) Snoke, D. W.; Wolfe, J. P.; Mysyrowics, A. Phys. Rev. B. 1990, 41, 11171.
- (12) Snoke, D. W.; Braun, D.; Cardona, M. Phys. Rev. B. 1991, 44, 2991.
- (13) Goto, T.; Shen, M. Y.; Koyama, S.; Yokouchi, T. Phys. Rev. B. 1997, 55, 7609.
- (14) Muramatsu, A.; Sugimoto, T. J. Colloid. Interface Sci. 1997, 189, 167-173.
- (15) Ponyatovskil, E. G.; Arosimova, G. E.; Aronin, A. S.; Kulakov, V. I.; Sinitsyn, V. V. Phys. Solid State 2002, 44, 852.
- (16) Mcfadyen, P.; Matijevic, E. J. Colloid. Interface Sci. 1973, 44, 95-106.
- (17) Son, S. U.; Park, I. K.; Park, J.; Hyeon, T. Chem. Commun. 2004, 778-779.
- (18) Gou, L.; Murphy, C. nano Lett. 2003, 3, 231.
- (19) Ayyub, P.; Palkar, V. R.; Chattopadhyay, S.; Multani, M. Phys. Rev. B 1995, 51, 6135.
- (20) Herhold, A. B.; Chen, C.-C.; Johnson, C. S.; Tolbert, S. H.; Alivisatos, A. P. Structural transformations and metastability in semiconductor nanocrystals, 1999; Vol. 68.
- (21) Qadri, S. B.; Skelton, E. F.; Hsu, D.; Dinsmore, A. D.; Yang, J.; Gray, H. F.; Ratna, B. R.
Phys. Rev. B 1999, 60, 9191. - (22) Pallkar, V. R.; Ayyub, P.; Chattopadhyay, S.; Multani, M. Phys. Rev. B. 1996, 53, 2167.
- (23) Yin, M.; Gu, Y.; Kuskovsky, I. L.; Andelman, T.; Zhu, Y.; Neumark, G. F.; O'Brien, S. J. Am. Chem. Soc. 2004, 126, 6206.
- (24) Yin, M.; O'Brien, S. J. Am. Chem. Soc. 2003, 125, 10180.
- (25) Park, J.; An, K.; Hwang, Y.; Park, J.-G.; Noh, H.-J.; Kim, J. Y.; Park, J.-H.; Hwang, N.-M.; Hyeon,
T. Nature Materials 2004, 3, 891-895. - (26) Redl, F. X.; Cho, K.-S.; Murray, C. B.; O'Brien, S, Nature 2003, 423, 968-971.
- All patent applications, published patent applications, issued and granted patents, texts, and literature references cited in this specification are hereby incorporated herein by reference in their entirety to more fully describe the state of the art to which the present invention pertains.
- As various changes can be made in the above methods and compositions without departing from the scope and spirit of the invention as described, it is intended that all subject matter contained in the above description, shown in the accompanying drawings, or defined in the appended claims be interpreted as illustrative, and not in a limiting sense.
Claims (33)
1. A method of preparing zinc oxide nanoparticles, comprising:
(a) mixing a zinc acetate precursor with an organic solvent comprising at least one organic stabilizing ligand to form a reaction mixture;
(b) subjecting the mixture of step (a) to a temperature of from about 300° C. to about 400° C. for a time sufficient to allow formation of zinc oxide nanoparticles and decomposition of the zinc acetate; and
(c) extracting the zinc oxide nanoparticles of step (b) into a hydrocarbon solvent at a temperature lower than the temperature of step (b) by precipitation with a flocculating agent.
2. The method according to claim 1 , wherein the temperature of step (b) is about 320° C. to about 400° C.
3. The method according to claim 1 , wherein the temperature of step (b) is about 360° C.
4. The method according to claim 1 , wherein the organic solvent of step (a) comprises a trialkylamine.
5. The method according to claim 4 , wherein the trialkylamine is trioctylamine.
6. The method according to claim 1 , wherein the organic stabilizing ligand is selected from the group consisting of sulfonic acid, sulfinic acid, phosphonic acid, phosphoric acid, a carboxylic acid, and a thiol.
7. The method according to claim 1 , wherein the organic stabilizing ligand is oleic acid.
8. The method according to claim 1 , wherein the zinc acetate precursor is anhydrous.
9. The method according to claim 1 , wherein, in step (a), the zinc acetate precursor is mixed with the organic solvent at room temperature to form the reaction mixture.
10. The method according to claim 1 , wherein, in step (b), the mixture is brought to said temperature in a time period of from about 10 minutes to about 30 minutes.
11. The method according to claim 10 , wherein, in step (b), the mixture is brought to said temperature in a time period of from about 10 minutes to about 15 minutes.
12. The method according to claim 1 , wherein the mixture of step (b) is maintained at said temperature for a time period of from about 45 minutes to about 1 hour to allow the formation of the zinc oxide nanoparticles.
13. The method according to claim 1 , wherein in step (c) the hydrocarbon solvent comprises pentane, hexane, heptane, octane, or dodecane.
14. The method according to claim 1 , wherein in step (c) the flocculating agent comprises a polar organic solvent.
15. The method according to claim 14 , wherein the polar organic solvent comprises methanol, ethanol, propanol, or butanol.
16. The method according to claim 1 , wherein, in step (c), the zinc oxide nanoparticles are extracted into an alkane solvent by precipitation with an alcohol or ketone.
17. The method according to claim 16 , wherein the zinc oxide nanoparticles are extracted into hexane solvent by precipitation with ethanol, followed by centrifugation and redispersion in hydrocarbon solvent.
18. The method according to claim 1 , wherein the extracted zinc oxide nanoparticles of step (c) are stable, monodisperse, and have uniform size.
19. The method according to claim 1 , wherein the zinc oxide nanoparticles have a size of about 2 nm to about 20 nm.
20. The method according to claim 1 , wherein, following step (b), the organic solvent is subjected to a second temperature of at least about 100° C. for a time sufficient to obtain zinc oxide nanoparticles having a specific diameter of about 10 nm to about 40 nm.
21. The method according to claim 1 , further comprising the step of subjecting the extracted zinc oxide nanoparticles obtained in step (c) to oxidation to obtain further oxidized zinc oxide nanoparticles.
22. The method according to claim 1 , wherein the extracted zinc oxide nanoparticles comprise nanorods, nanotriangles, or nanospheres.
23. The zinc oxide nanoparticles according to claim 22 .
24. The method according to claim 1 , wherein the nanoparticles comprise nanospheres, wherein the molar ratio of the zinc acetate precursor to the at least one organic stabilizing ligand in step (a) is greater than about 1:3.
25. The method according to claim 24 , wherein the organic solvent of step (a) comprises an alcohol or hydrocarbon solvent.
26. The method according to claim 25 , wherein the alcohol is 1-hexadecanol, or wherein the hydrocarbon solvent is 1-octadecene.
27. A method of preparing zinc oxide nanorods, comprising:
(a) mixing a zinc acetate precursor with an organic solvent comprising a carboxylic acid to form a reaction mixture, wherein the molar ratio of the zinc acetate precursor to the carboxylic acid in step (a) is less than about 1:2;
(b) subjecting the mixture of step (a) to a temperature of from about 300° C. to about 400° C. for a time sufficient to allow formation of zinc oxide nanorods and decomposition of the zinc acetate; and
(c) extracting the zinc oxide nanorods of step (b) into a hydrocarbon solvent at a temperature lower than the temperature of step (b) by precipitation with a flocculating agent.
28. The method according to claim 27 , wherein the carboxylic acid is oleic acid.
29. The method according to claim 27 , wherein the organic solvent of step (a) comprises a trialkylamine.
30. The method according to claim 29 , wherein the trialkylamine is trioctylamine.
31. The method according to claim 27 , wherein the nanorods have diameters of about 2 nm to about 10 nm.
32. The method according to claim 27 , wherein the nanorods have aspect ratios of about 1:5 to about 1:40.
33. The zinc oxide nanorods according to claim 27 .
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/444,178 US20120225006A1 (en) | 2003-12-11 | 2012-04-11 | Nano-sized particles, processes of making, compositions and uses thereof |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US52866703P | 2003-12-11 | 2003-12-11 | |
PCT/US2004/041141 WO2005060610A2 (en) | 2003-12-11 | 2004-12-09 | Nano-sized particles, processes of making, compositions and uses thereof |
US11/451,251 US8182786B2 (en) | 2003-12-11 | 2006-06-12 | Nano-sized particles, processes of making, compositions and uses thereof |
US13/444,178 US20120225006A1 (en) | 2003-12-11 | 2012-04-11 | Nano-sized particles, processes of making, compositions and uses thereof |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/451,251 Continuation US8182786B2 (en) | 2003-12-11 | 2006-06-12 | Nano-sized particles, processes of making, compositions and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
US20120225006A1 true US20120225006A1 (en) | 2012-09-06 |
Family
ID=34710091
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/451,251 Expired - Fee Related US8182786B2 (en) | 2003-12-11 | 2006-06-12 | Nano-sized particles, processes of making, compositions and uses thereof |
US13/444,178 Abandoned US20120225006A1 (en) | 2003-12-11 | 2012-04-11 | Nano-sized particles, processes of making, compositions and uses thereof |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/451,251 Expired - Fee Related US8182786B2 (en) | 2003-12-11 | 2006-06-12 | Nano-sized particles, processes of making, compositions and uses thereof |
Country Status (2)
Country | Link |
---|---|
US (2) | US8182786B2 (en) |
WO (1) | WO2005060610A2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090297626A1 (en) * | 2006-11-03 | 2009-12-03 | The Trustees Of Columbia University In The City Of New York | Methods for preparing metal oxides |
US20140170818A1 (en) * | 2005-08-09 | 2014-06-19 | Cambridge Enterprise Limited | Nanorod thin-film transistors |
WO2017037731A1 (en) * | 2015-08-29 | 2017-03-09 | Indian Institute Of Technology Bombay | Enhanced photostability, extended range uva filtering and camouflaging potential of avobenzone-defect rich zno nanocrystals complex |
WO2024063744A3 (en) * | 2022-09-23 | 2024-05-23 | Bilkent Universitesi Ulusal Nanoteknoloji Arastirma Merkezi | A method used for transportation of colloidal quantum well self-assembly |
Families Citing this family (84)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6962685B2 (en) * | 2002-04-17 | 2005-11-08 | International Business Machines Corporation | Synthesis of magnetite nanoparticles and the process of forming Fe-based nanomaterials |
FR2853307B1 (en) * | 2003-04-07 | 2006-07-07 | Centre Nat Rech Scient | PROCESS FOR PREPARING A COMPOSITION OF NANOPARTICLES OF AT LEAST ONE CRYSTALLINE METAL OXIDE |
WO2005060610A2 (en) * | 2003-12-11 | 2005-07-07 | The Trustees Of Columbia University In The City Ofnew York | Nano-sized particles, processes of making, compositions and uses thereof |
US7507618B2 (en) * | 2005-06-27 | 2009-03-24 | 3M Innovative Properties Company | Method for making electronic devices using metal oxide nanoparticles |
US8697019B2 (en) * | 2005-10-14 | 2014-04-15 | Inframat Corporation | Nanostructured compositions having reduced dissolution of manganese and methods of making and using the same |
JP5355095B2 (en) | 2006-02-16 | 2013-11-27 | ブリガム・ヤング・ユニバーシティ | Production of uniform nanoparticles of ultra-high purity metal oxides, mixed metal oxides, metals, and alloys |
WO2007117503A2 (en) * | 2006-04-07 | 2007-10-18 | The Trustees Of Columbia University In The City Of New York | Preparing nanoparticles and carbon nanotubes |
WO2007136488A2 (en) * | 2006-04-20 | 2007-11-29 | The Trustees Of Columbia University In The City Of New York | Copper oxide nanoparticle system |
DE102006023244A1 (en) * | 2006-05-18 | 2007-11-22 | Lanxess Deutschland Gmbh | Oxidation-stable iron oxide pigments, process for their preparation and their use |
US9978413B2 (en) | 2006-06-17 | 2018-05-22 | Dieter Suess | Multilayer exchange spring recording media |
US9719019B1 (en) | 2006-10-30 | 2017-08-01 | Alan M. Gilbert | Flame-retardant materials and systems |
US20080111114A1 (en) * | 2006-10-30 | 2008-05-15 | Gilbert Alan M | Flame-retardant materials and systems |
US9017584B2 (en) * | 2006-10-30 | 2015-04-28 | Alan M. Gilbert | Flame-retardant materials and systems |
WO2008147395A2 (en) * | 2006-11-10 | 2008-12-04 | Grune Guerry L | Anti-microbial compounds used in garments for water based activities |
US20110189101A1 (en) * | 2006-12-01 | 2011-08-04 | National University Corporation Shimane University | Fluorescent labeling agent and fluorescent labeling method |
US8741821B2 (en) * | 2007-01-03 | 2014-06-03 | Afton Chemical Corporation | Nanoparticle additives and lubricant formulations containing the nanoparticle additives |
US20080164141A1 (en) * | 2007-01-08 | 2008-07-10 | Mohamed Samy Sayed El-Shall | Methods for making metal-containing nanoparticles of controlled size and shape |
US7766983B2 (en) * | 2007-03-07 | 2010-08-03 | General Electric Company | Nanostructured corrosion inhibitors and methods of use |
WO2008135093A1 (en) * | 2007-05-08 | 2008-11-13 | Nm Tech Nanomaterials Microdevice Technology Ltd. | Products comprising an anti-microbial composition based on titanium dioxide nanoparticles |
US8367506B2 (en) | 2007-06-04 | 2013-02-05 | Micron Technology, Inc. | High-k dielectrics with gold nano-particles |
KR100869026B1 (en) * | 2007-07-25 | 2008-11-17 | 주식회사 엘지화학 | Spherical assembly particle composition of cuprous oxide and preparation method thereof |
KR20090032839A (en) * | 2007-09-28 | 2009-04-01 | 삼성전기주식회사 | Method for manufacturing copper-based nanoparticles |
CN101407332B (en) * | 2007-10-12 | 2011-04-27 | 新疆大学 | Hydro-thermal synthesis method for cupric oxide nano-rod |
JP2011502946A (en) * | 2007-11-14 | 2011-01-27 | アドバンスド テクノロジー マテリアルズ,インコーポレイテッド | Solvent-free synthesis of soluble nanocrystals |
US7785998B2 (en) * | 2008-02-21 | 2010-08-31 | Micron Technology, Inc. | Methods of forming dispersions of nanoparticles, and methods of forming flash memory cells |
ATE549297T1 (en) * | 2008-03-10 | 2012-03-15 | Tata Chemicals Ltd | METHOD FOR PRODUCING NANOZINCOXIDE PARTICLES |
US20110182946A1 (en) * | 2008-03-17 | 2011-07-28 | Board Of Regents, The University Of Texas System | Formation of Nanostructured Particles of Poorly Water Soluble Drugs and Recovery by Mechanical Techniques |
US20090253072A1 (en) * | 2008-04-01 | 2009-10-08 | Petruska Melissa A | Nanoparticle reversible contrast enhancement material and method |
US20090260645A1 (en) * | 2008-04-14 | 2009-10-22 | Nanoscale Corporation | Method for neutralization, adsorption, and absorption of hazardous or otherwise undesired compounds in a tobacco product |
DE102008026210B4 (en) | 2008-05-30 | 2012-06-28 | Süd-Chemie AG | Nanocrystalline copper oxide and process for its preparation |
US8221791B1 (en) | 2008-12-10 | 2012-07-17 | University Of Central Florida Research Foundation, Inc. | Silica-based antibacterial and antifungal nanoformulation |
US9520217B2 (en) * | 2008-12-11 | 2016-12-13 | Lawrence Livermore National Security, Llc | Methods for creating ligand induced paramagnetism in nanocrystalline structures |
US8790614B2 (en) | 2009-01-09 | 2014-07-29 | Colorado School Of Mines | ZnO structures and methods of use |
US8791191B2 (en) | 2009-02-03 | 2014-07-29 | Buehler Partec Gmbh | Zinc oxide particles which have been modified with phosphonocarboxylic acid and use of zinc oxide particles |
EP2241602A1 (en) * | 2009-04-17 | 2010-10-20 | Bühler PARTEC GmbH | Zinc oxide particle modified with phosphonocarboxylic acid and use of same |
WO2010110726A1 (en) * | 2009-03-23 | 2010-09-30 | Välinge Innovation AB | Production of titania nanoparticle colloidal suspensions with maintained crystallinity by using a bead mill with micrometer sized beads |
CN101786602B (en) * | 2010-03-24 | 2013-01-23 | 吉林大学 | Method for preparing oil-soluble semiconductor nanocrystals in liquid paraffin by one-pot method |
US9017578B2 (en) * | 2010-05-31 | 2015-04-28 | National Institute For Materials Science | Method for producing a metal nanoparticle colloid |
US9572880B2 (en) | 2010-08-27 | 2017-02-21 | Sienna Biopharmaceuticals, Inc. | Ultrasound delivery of nanoparticles |
EP2608762B2 (en) | 2010-08-27 | 2020-05-13 | Sienna Biopharmaceuticals, Inc. | Compositions and methods for targeted thermomodulation |
US8333945B2 (en) | 2011-02-17 | 2012-12-18 | Afton Chemical Corporation | Nanoparticle additives and lubricant formulations containing the nanoparticle additives |
US9849512B2 (en) | 2011-07-01 | 2017-12-26 | Attostat, Inc. | Method and apparatus for production of uniformly sized nanoparticles |
US11045798B2 (en) | 2011-07-05 | 2021-06-29 | Valinge Photocatalytic Ab | Coated wood products and method of producing coated wood products |
US9079164B2 (en) | 2012-03-26 | 2015-07-14 | Brigham Young University | Single reaction synthesis of texturized catalysts |
US9114378B2 (en) | 2012-03-26 | 2015-08-25 | Brigham Young University | Iron and cobalt based fischer-tropsch pre-catalysts and catalysts |
US9017468B2 (en) | 2012-04-25 | 2015-04-28 | Hewlett-Packard Development Company, L.P. | Colorant dispersion for an ink |
JP6325552B2 (en) | 2012-10-11 | 2018-05-16 | ナノコンポジックス,インコーポレイテッド | Silver nanoplate compositions and methods |
US9375750B2 (en) | 2012-12-21 | 2016-06-28 | Valinge Photocatalytic Ab | Method for coating a building panel and a building panel |
CN103896340A (en) * | 2012-12-27 | 2014-07-02 | 中国石油天然气股份有限公司 | Method for preparing trimanganese tetroxide nano particles with adjustable sizes by adopting solvothermal method |
US9289750B2 (en) | 2013-03-09 | 2016-03-22 | Brigham Young University | Method of making highly porous, stable aluminum oxides doped with silicon |
JP5914890B2 (en) * | 2013-03-13 | 2016-05-11 | パナソニックIpマネジメント株式会社 | Copper composite titanium oxide dispersion, coating composition and antibacterial / antiviral component |
JP6390888B2 (en) * | 2013-03-27 | 2018-09-19 | アイシン精機株式会社 | Method for producing nanoparticles containing FeO as a main component |
US20140329005A1 (en) * | 2013-05-01 | 2014-11-06 | Microreactor Solutions Llc | Supercritical deposition of protective films on electrically conductive particles |
FR3008103B1 (en) * | 2013-07-03 | 2015-09-11 | Genes Ink Sas | INK COMPOSITION BASED ON NANOPARTICLES |
JP6363827B2 (en) * | 2013-08-28 | 2018-07-25 | 国立大学法人 岡山大学 | Method for producing cuprous oxide nanoparticles |
US9945075B2 (en) | 2013-09-25 | 2018-04-17 | Valinge Photocatalytic Ab | Method of applying a photocatalytic dispersion |
WO2015095068A1 (en) * | 2013-12-16 | 2015-06-25 | The Texas A&M University System | Systems and methods for in-situ formation of nanoparticles and nanofins |
US20180280545A1 (en) * | 2014-11-04 | 2018-10-04 | University Of Washington | Iron oxide nanoparticles and their synthesis by controlled oxidation |
CN104436222A (en) * | 2014-12-11 | 2015-03-25 | 厦门大学 | Synthesis method of MnO nanometer material of T1 contrast agent |
KR101621701B1 (en) | 2014-12-29 | 2016-05-17 | 고려대학교 산학협력단 | Metal oxide nanoparticles and the prosess of manufacture |
WO2016161348A1 (en) | 2015-04-01 | 2016-10-06 | Attostat, Inc. | Nanoparticle compositions and methods for treating or preventing tissue infections and diseases |
EP3283580A4 (en) | 2015-04-13 | 2019-03-20 | Attostat, Inc. | Anti-corrosion nanoparticle compositions |
US11473202B2 (en) | 2015-04-13 | 2022-10-18 | Attostat, Inc. | Anti-corrosion nanoparticle compositions |
JPWO2017086376A1 (en) * | 2015-11-20 | 2018-09-06 | コニカミノルタ株式会社 | Method for producing vanadium dioxide-containing particles |
US10201571B2 (en) | 2016-01-25 | 2019-02-12 | Attostat, Inc. | Nanoparticle compositions and methods for treating onychomychosis |
CN106430278B (en) * | 2016-09-28 | 2017-08-25 | 益阳鸿源稀土有限责任公司 | A kind of preparation method of high-pure anhydrous acetic acid scandium and High-purity Sc Oxide |
WO2021067751A1 (en) | 2019-10-03 | 2021-04-08 | Noctrix Health, Inc. | Peripheral nerve stimulation for restless legs syndrome |
WO2018191615A1 (en) * | 2017-04-14 | 2018-10-18 | Northwestern University | Metal-substituted metal oxide materials for lithium ion batteries |
CN107162036B (en) * | 2017-05-15 | 2018-09-21 | 南京大学 | A kind of nanocrystalline Y2O3And preparation method thereof |
US10450201B2 (en) | 2017-10-04 | 2019-10-22 | King Fahd University Of Petroleum And Minerals | Method for the synthesis of nanoparticles of heterometallic nanocomposite materials |
US11646453B2 (en) | 2017-11-28 | 2023-05-09 | Attostat, Inc. | Nanoparticle compositions and methods for enhancing lead-acid batteries |
US11018376B2 (en) | 2017-11-28 | 2021-05-25 | Attostat, Inc. | Nanoparticle compositions and methods for enhancing lead-acid batteries |
US10883183B2 (en) | 2018-04-13 | 2021-01-05 | Honda Motor Co., Ltd. | Method of preparing copper-copper nitride nanocatalysts for carbon dioxides reduction reaction |
WO2020004644A1 (en) * | 2018-06-29 | 2020-01-02 | 国立研究開発法人産業技術総合研究所 | Nanocrystal and method for manufacturing same, and electronic device and piezoelectric element using nanocrystal |
RU2693200C1 (en) * | 2018-08-23 | 2019-07-01 | Автономная некоммерческая образовательная организация высшего образования "Сколковский институт науки и технологий" | Method of producing nanoparticles of manganese oxides and aerogels based thereon and aerogel obtained by this method |
JP7502799B2 (en) * | 2019-02-27 | 2024-06-19 | 学校法人立命館 | Nanoparticles for photochromic materials and aqueous dispersion of nanoparticles for photochromic materials |
US11767466B2 (en) | 2019-04-17 | 2023-09-26 | Saudi Arabian Oil Company | Nanocomposite coated proppants and methods of making same |
EP3956418A1 (en) | 2019-04-17 | 2022-02-23 | Saudi Arabian Oil Company | Methods of suspending weighting agents in a drilling fluid |
US11377944B2 (en) | 2019-04-17 | 2022-07-05 | Saudi Arabian Oil Company | Methods of suspending proppants in hydraulic fracturing fluid |
US11370951B2 (en) | 2019-04-17 | 2022-06-28 | Saudi Arabian Oil Company | Methods of suspending weighting agents in a drilling fluid |
US11370706B2 (en) | 2019-07-26 | 2022-06-28 | Saudi Arabian Oil Company | Cement slurries, cured cement and methods of making and use thereof |
US10933403B1 (en) | 2020-08-27 | 2021-03-02 | King Abdulaziz University | Methods for the decoration of carbon nanoparticles with hafnium promethium oxide nanowires for energy applications |
CN112939058A (en) * | 2021-02-19 | 2021-06-11 | 安徽景成新材料有限公司 | Hydrothermal synthesis method for preparing novel zinc oxide with special crystal morphology |
CN114405304B (en) * | 2022-02-17 | 2023-08-08 | 河北科技大学 | Composition for dispersing nickel oxide in organic solvent and dispersing method |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8182786B2 (en) * | 2003-12-11 | 2012-05-22 | The Trustees Of Columbia University In The City Of New York | Nano-sized particles, processes of making, compositions and uses thereof |
Family Cites Families (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3581293D1 (en) * | 1984-02-09 | 1991-02-21 | Toyota Motor Co Ltd | METHOD FOR PRODUCING ULTRAFINE CERAMIC PARTICLES. |
US4649037A (en) * | 1985-03-29 | 1987-03-10 | Allied Corporation | Spray-dried inorganic oxides from non-aqueous gels or solutions |
US5133974A (en) * | 1989-05-05 | 1992-07-28 | Kv Pharmaceutical Company | Extended release pharmaceutical formulations |
GB9020075D0 (en) * | 1990-09-14 | 1990-10-24 | Filler Aaron G | Contrast agents for magnetic resonance imaging of axonal transport |
US5766635A (en) * | 1991-06-28 | 1998-06-16 | Rhone-Poulenc Rorer S.A. | Process for preparing nanoparticles |
FR2680684B1 (en) * | 1991-08-29 | 1993-11-12 | Oreal | COSMETIC FILTERING COMPOSITION COMPRISING A METAL OXIDE NANOPIGMENT AND A FILTERED POLYMER. |
CN1064777C (en) * | 1993-06-24 | 2001-04-18 | 卡耐基米龙大学 | Metal, alloy, or metal carbide nanoparticles and process for forming same |
US5716565A (en) * | 1993-09-27 | 1998-02-10 | Alfred University | Process for making ultra-fine stabilized zirconia particles |
WO1995033688A1 (en) * | 1994-06-06 | 1995-12-14 | Nippon Shokubai Co., Ltd. | Fine zinc oxide particles, process for producing the same, and use thereof |
DE4428851C2 (en) * | 1994-08-04 | 2000-05-04 | Diagnostikforschung Inst | Nanoparticles containing iron, their production and application in diagnostics and therapy |
US5472749A (en) * | 1994-10-27 | 1995-12-05 | Northwestern University | Graphite encapsulated nanophase particles produced by a tungsten arc method |
US6143211A (en) * | 1995-07-21 | 2000-11-07 | Brown University Foundation | Process for preparing microparticles through phase inversion phenomena |
DE19543204C2 (en) * | 1995-11-20 | 1997-09-18 | Bayer Ag | Process for the production of nanodisperse titanium dioxide and its use |
EP0792688A1 (en) * | 1996-03-01 | 1997-09-03 | Dow Corning Corporation | Nanoparticles of silicon oxide alloys |
US6162530A (en) * | 1996-11-18 | 2000-12-19 | University Of Connecticut | Nanostructured oxides and hydroxides and methods of synthesis therefor |
US6451220B1 (en) * | 1997-01-21 | 2002-09-17 | Xerox Corporation | High density magnetic recording compositions and processes thereof |
US6168798B1 (en) * | 1997-02-03 | 2001-01-02 | Bristol-Myers Squibb Company | Non-irritating composition for treating acne and other skin conditions |
US5948483A (en) * | 1997-03-25 | 1999-09-07 | The Board Of Trustees Of The University Of Illinois | Method and apparatus for producing thin film and nanoparticle deposits |
US6506493B1 (en) * | 1998-11-09 | 2003-01-14 | Nanogram Corporation | Metal oxide particles |
US5952125A (en) * | 1997-07-21 | 1999-09-14 | Nanogram Corporation | Batteries with electroactive nanoparticles |
US5885596A (en) * | 1997-07-23 | 1999-03-23 | Bristol-Myers Squibb Company | Methods and compositions for fine lines and/or wrinkles |
US5879715A (en) * | 1997-09-02 | 1999-03-09 | Ceramem Corporation | Process and system for production of inorganic nanoparticles |
AUPP004497A0 (en) * | 1997-10-28 | 1997-11-20 | University Of Melbourne, The | Stabilized particles |
US5958329A (en) * | 1997-11-06 | 1999-09-28 | United States Enrichment Corporation | Method and apparatus for producing nanoparticles at a high rate |
JP3080162B2 (en) * | 1998-01-27 | 2000-08-21 | 日本パーカライジング株式会社 | Titanium oxide sol and method for producing the same |
FR2780901B1 (en) * | 1998-07-09 | 2000-09-29 | Coletica | PARTICLES, IN PARTICULAR MICRO- OR NANOPARTICLES OF CROSSLINKED MONOSACCHARIDES AND OLIGOSACCHARIDES, THEIR PREPARATION METHODS AND COSMETIC, PHARMACEUTICAL OR FOOD COMPOSITIONS CONTAINING THE SAME |
US6036886A (en) * | 1998-07-29 | 2000-03-14 | Nanocrystals Technology L.P. | Microemulsion method for producing activated metal oxide nanocrystals |
US6262129B1 (en) * | 1998-07-31 | 2001-07-17 | International Business Machines Corporation | Method for producing nanoparticles of transition metals |
US6416818B1 (en) * | 1998-08-17 | 2002-07-09 | Nanophase Technologies Corporation | Compositions for forming transparent conductive nanoparticle coatings and process of preparation therefor |
US6375986B1 (en) * | 2000-09-21 | 2002-04-23 | Elan Pharma International Ltd. | Solid dose nanoparticulate compositions comprising a synergistic combination of a polymeric surface stabilizer and dioctyl sodium sulfosuccinate |
CN1094467C (en) * | 1999-02-15 | 2002-11-20 | 上海跃龙有色金属有限公司 | Nm-class compound Ce-Zr oxide and its preparing process and application |
US6235540B1 (en) * | 1999-03-30 | 2001-05-22 | Coulter International Corp. | Semiconductor nanoparticles for analysis of blood cell populations and methods of making same |
US6254662B1 (en) * | 1999-07-26 | 2001-07-03 | International Business Machines Corporation | Chemical synthesis of monodisperse and magnetic alloy nanocrystal containing thin films |
US6416862B1 (en) * | 1999-08-25 | 2002-07-09 | Showa Denko K. K. | Ultrafine particulate zinc oxide and production process thereof |
DE60037267T2 (en) * | 1999-10-06 | 2008-10-09 | Oxonica, Inc., Mountain View | SURFACE IMPROVED SPECTROSCOPIC ACTIVE COMPOSITE NANOPARTICLES |
US6440213B1 (en) * | 1999-10-28 | 2002-08-27 | The Regents Of The University Of California | Process for making surfactant capped nanocrystals |
WO2001037721A2 (en) * | 1999-11-22 | 2001-05-31 | The Research Foundation Of State University Of New York | Magnetic nanoparticles for selective therapy |
US6530944B2 (en) * | 2000-02-08 | 2003-03-11 | Rice University | Optically-active nanoparticles for use in therapeutic and diagnostic methods |
JP3517698B2 (en) * | 2000-03-03 | 2004-04-12 | 独立行政法人産業技術総合研究所 | Nanoparticle dispersed structure and laminate thereof |
US6403653B1 (en) * | 2000-06-02 | 2002-06-11 | The United States Of America As Represented By The Secretary Of The Army | Active topical skin protectants using reactive nanoparticles |
WO2002009884A2 (en) * | 2000-07-28 | 2002-02-07 | Simon Fraser University | Methods for the lithographic deposition of materials containing nanoparticles |
US6623761B2 (en) * | 2000-12-22 | 2003-09-23 | Hassan Emadeldin M. | Method of making nanoparticles of substantially water insoluble materials |
KR100867281B1 (en) * | 2001-10-12 | 2008-11-06 | 재단법인서울대학교산학협력재단 | Synthesis of Monodisperse and Highly-Crystalline Nanoparticles of Metals, Alloys, Metal Oxides, and Multi-metallic Oxides without a Size-selection Process |
US20040161380A1 (en) * | 2003-02-19 | 2004-08-19 | Degussa Ag | Titanium dioxide particles, their preparation and use |
WO2004087577A1 (en) | 2003-03-31 | 2004-10-14 | Toto Ltd. | Surface-modified titanium dioxide fine particles and dispersion comprising the same, and method for producing the same |
US20090297626A1 (en) * | 2006-11-03 | 2009-12-03 | The Trustees Of Columbia University In The City Of New York | Methods for preparing metal oxides |
-
2004
- 2004-12-09 WO PCT/US2004/041141 patent/WO2005060610A2/en active Application Filing
-
2006
- 2006-06-12 US US11/451,251 patent/US8182786B2/en not_active Expired - Fee Related
-
2012
- 2012-04-11 US US13/444,178 patent/US20120225006A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8182786B2 (en) * | 2003-12-11 | 2012-05-22 | The Trustees Of Columbia University In The City Of New York | Nano-sized particles, processes of making, compositions and uses thereof |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20140170818A1 (en) * | 2005-08-09 | 2014-06-19 | Cambridge Enterprise Limited | Nanorod thin-film transistors |
US9275856B2 (en) * | 2005-08-09 | 2016-03-01 | Cambridge Enterprise Limited | Nanorod thin-film transistors |
US20090297626A1 (en) * | 2006-11-03 | 2009-12-03 | The Trustees Of Columbia University In The City Of New York | Methods for preparing metal oxides |
WO2017037731A1 (en) * | 2015-08-29 | 2017-03-09 | Indian Institute Of Technology Bombay | Enhanced photostability, extended range uva filtering and camouflaging potential of avobenzone-defect rich zno nanocrystals complex |
WO2024063744A3 (en) * | 2022-09-23 | 2024-05-23 | Bilkent Universitesi Ulusal Nanoteknoloji Arastirma Merkezi | A method used for transportation of colloidal quantum well self-assembly |
Also Published As
Publication number | Publication date |
---|---|
WO2005060610A2 (en) | 2005-07-07 |
US20070140951A1 (en) | 2007-06-21 |
WO2005060610A3 (en) | 2005-09-22 |
US8182786B2 (en) | 2012-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8182786B2 (en) | Nano-sized particles, processes of making, compositions and uses thereof | |
Salavati-Niasari et al. | A novel precursor in preparation and characterization of nickel oxide nanoparticles via thermal decomposition approach | |
Pal et al. | Study of physical properties of cobalt oxide (Co3O4) nanocrystals | |
US7547347B2 (en) | Synthesis of nano-materials in ionic liquids | |
Davar et al. | Thermal decomposition route for synthesis of Mn3O4 nanoparticles in presence of a novel precursor | |
KR101304080B1 (en) | New Process For Large-Scale Production of Monodisperse Nanoparticles | |
KR100604975B1 (en) | Preparation Method of Magnetic and Metal Oxide Nanoparticles | |
Mohamed et al. | CuO nanobelts synthesized by a template-free hydrothermal approach with optical and magnetic characteristics | |
Caruntu et al. | Reactivity of 3d transition metal cations in diethylene glycol solutions. Synthesis of transition metal ferrites with the structure of discrete nanoparticles complexed with long-chain carboxylate anions | |
Solano et al. | Facile and efficient one-pot solvothermal and microwave-assisted synthesis of stable colloidal solutions of MFe 2 O 4 spinel magnetic nanoparticles | |
Poul et al. | Metastable solid solutions in the system ZnO CoO: synthesis by hydrolysis in polyol medium and study of the morphological characteristics | |
UmaSudharshini et al. | Low temperature solvothermal synthesis of pristine Co3O4 nanoparticles as potential supercapacitor | |
Corr | Metal oxide nanoparticles | |
Salavati-Niasari et al. | Synthesis and characterization of Co 3 O 4 nanoparticles by a simple method | |
Gervas et al. | Synthesis of rare pure phase Ni3S4 and Ni3S2 nanoparticles in different primary amine coordinating solvents | |
Tripathy et al. | Hydrothermal synthesis of single-crystalline nanocubes of Co3O4 | |
Omorogbe et al. | Low-temperature synthesis of superparamagnetic Fe 3 O 4 morphologies tuned using oleic acid as crystal growth modifiers | |
Sobhani et al. | Synthesis, characterization, optical and magnetic properties of a nickel sulfide series by three different methods | |
Gautam et al. | A strategy for the synthesis of nanocrystal films of metal chalcogenides and oxides by employing the liquid–liquid interface | |
Yang et al. | Morphology-controlled synthesis of anisotropic wurtzite MnSe nanocrystals: optical and magnetic properties | |
Lassoued et al. | Nanocrystalline Ni x Co (0.5− x) Zn 0.5 Fe 2 O 4 ferrites: fabrication through co-precipitation route with enhanced structural, magnetic and photo-catalytic activity | |
Li et al. | Size-controlled syntheses and hydrophilic surface modification of Fe 3 O 4, Ag, and Fe 3 O 4/Ag heterodimer nanocrystals | |
Nguyen et al. | Synthesis and magnetic characteristics of neodymium ferrite powders with perovskite structure | |
Lukashin et al. | Chemical design of magnetic nanocomposites based on layered double hydroxides | |
US11305351B2 (en) | Magnetic nanoparticles and methods of making magnetic nanoparticles |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: NATIONAL SCIENCE FOUNDATION, VIRGINIA Free format text: CONFIRMATORY LICENSE;ASSIGNOR:COLUMBIA UNIVERSITY NEW YORK MORNINGSIDE;REEL/FRAME:028501/0604 Effective date: 20120703 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |